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Abstract
The final size and shape of the brain is specified during neurogenesis by complex 
spatiotemporal patterns of cell proliferation and cell death. Many of the 
developmental genes regulating these two cellular processes remain to be identified. 
In the holometabolous insect Drosophila, neurogenesis involves distinct embryonic 
and postembryonic phases. To identify new regulators of Drosophila postembryonic 
neurogenesis, I conducted two genetic screens. First, a screen of 350 mutagenised 
chromosomes was used to isolate 22 pupal-lethal mutations associated with an 
undersized and/or mis-shapened central nervous system. And second, a larger mosaic 
screen of 1,250 mutagenised chromosomes identified 68 embryonic-lethal mutations 
altering the number of neurons generated per neural progenitor (neuroblast).
Two of the mutations associated with neuroblast clones containing greatly reduced 
numbers of neurons were mapped to an uncharacterised gene, CG31005 that I have 
named qless. Sequence analysis indicates that qless encodes a fly orthologue of 
human prenyl diphosphate synthase subunit 1 (PDSSl), the mitochondrial enzyme 
that synthesises the isoprenyl side-chains of Coenzyme-Q (CoQ). CoQ is a potent 
antioxidant and plays a key role in generating cellular ATP via oxidative 
phosphorylation. Patients with mutations in PDSSl, present a range of pathologies 
including neural degeneration and mental retardation. In Drosophila, oxidative 
phosphorylation appears capable of utilising CoQ with anywhere between 4-10 
isoprenyl groups as the qless phenotype can be rescued by dietary supplementation 
with CoQ4, CoQ9 or CoQ 10. Neurons lacking qless activity express activated 
caspase and their mitochondria display elevated levels of a Cytochrome c epitope 
associated with apoptosis. Together, these studies of qless shed light on the poorly 
understood contribution of mitochondria to apoptosis in Drosophila and also provide 
a genetically tractable model for studying human CoQ deficiencies.
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1.Introduction
The final size and shape of the brain is specified during development by complex 
spatiotemporal patterns of cell proliferation and cell death. Neural cell number can 
be modulated by regulating the number of times a neural stem cell (NSC) or 
progenitor divides. In turn, this can be influenced by cell-cycle entry or exit and also 
by progenitor death. Although not discussed in this thesis, cell death can also 
regulate cell number after neurogenesis has been completed, via the editing out of 
post-mitotic neurons that fail to innervate their targets correctly (Oppenheim, 1991). 
The identification of new genes that control either proliferation or death of neural 
precursor cells will provide important insights into how brain size is regulated.
l,l.M ammalian neurogenesis
The building blocks of the mammalian central nervous system (CNS) are neural stem 
and progenitor cells. Two criteria are often used to define a cell as a stem cell, it has 
to be able to self-renew for many cell divisions and has to be multipotent with the 
ability to generate numerous differentiated cell types. Progenitor is the collective 
name for both stem cells and non-stem-cell progenitors. Neural non-stem-cell 
progenitors usually undergo symmetric differentiating divisions each of which 
produce two post-mitotic neuronal cells. In principle, neural progenitors can divide 
symmetrically or asymmetrically (Fig. 1.1). The purpose of symmetrical division is 
to give rise to two daughter cells of the same type, for example to increase the 
progenitor pool or to exit the cell cycle via two differentiated post-mitotic cells. The 
purpose of asymmetric division is to generate two different daughter cells, one of 
which is often identical to the mother cell and the other a more restricted 
intermediate or a differentiated cell type. Both types of division have been observed 
during vertebrate neurogenesis (Gotz and Hunter, 2005; Molyneaux et al., 2007). 
Live imaging of labelled progenitors in the CNS indicates that the majority of 
neurons, 84% in the hindbrain, are generated by symmetric divisions in the zebrafish 
(Lyons et al., 2003). During development of the mammalian cerebral cortex many of 
the details concerning when and where symmetric and asymmetric divisions are
II
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Symmetric division Asymmetric division
FIGURE 1.1. S y m m e t r i c  a n d  A s y m m e t r i c  d i v i s i o n . Symmetric division 
of neural progenitors (blue) can increase the progenitor pool. Asymmetric 
division of progenitors can allow self-renewal and the production of 
differentiated cells such as neurons (red).
utilised remain to be worked out. However, early neuroepithelial cells are known to 
undergo extensive proliferation dividing symmetrically to expand the initial 
progenitor pool. These neuroepithelial cells then give rise to multipotent progenitors 
such as radial glia. These, in turn, appear to generate all the differentiated cells in the 
CNS via the production of intermediate precursors, also known as transit-amplifying 
cells, such as neuroblasts (NBs) and glioblasts (Doetsch et al., 2002; Lyons et al.,
2003). Intermediate progenitors undergo repeated asymmetric divisions, self- 
renewing and producing several different types of neurons that migrate to a precise 
final destination. There are six distinct neuronal layers in the cerebral cortex, each 
layer consisting of neurons with specific morphology, function and connectivity. As 
each cortical layer develops, progenitors become progressively restricted from 
generating the earlier-born neuronal types. With the exception of the Cajal-Retzius 
cells which reside in layer 1, the cerebral cortex is formed in an “inside-out manner” 
(Berry et al., 1964). Layer 1 is produced first, followed by layers 6, 5, 4 and 2/3. 
Therefore, the birth-date of the neuron predicts its identity. Neurons which migrate 
to form the deepest 5^ and 6^ layers are bom first while those destined for the more
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superficial layers are the later bom neurons (Brown et ah, 2001; Hanashima et al., 
2004; McConnell, 1988; Rakic, 1974; Shen et al., 2006). The first restriction in 
neuronal cell types in the cortex is the transition from the generation of Cajal-Retzius 
neurons to the production of deep-layer neurons. Research has now shown that one 
gene that affects this early cortical stage is Foxgl, which encodes a transcriptional 
repressor that is expressed in neuroblasts but not in early-bom Cajal-Retzius cells. In 
loss-of-function mutations in mice, supernumerary Cajal-Retzius neurons are 
observed (Hanashima et al., 2004). Together, the evidence indicates that Foxgl 
functions cell-autonomously to repress the production of Cajal-Retzius neurons after 
their normal birth date, hence suppressing this early-bom cell fate during the 
subsequent generation of the cortical laminae (Desai and McConnell, 2000; Frantz 
and McConnell, 1996; Hanashima et al., 2004; Shen et al., 2006). Other genes 
known to be cmcial for the specification of the different cortical layers are TIM 
homeobox 2 (Lhx2), empty spiracles homologue 2 (Emx2) and paired box 6 (Pax6) 
(Cecchi, 2002; Molyneaux et al., 2007). Intrinsic cues appear to be involved in 
generating layer-specific neuronal identities from initial progenitors, as the process 
can be recapitulated by selected progenitors in vitro (Cecchi, 2002; Shen et al.,
2006).
Birth-order dependent neuronal fates have also been observed in the vertebrate 
retina, hindbrain and spinal cord (Donovan and Dyer, 2005; Livesey and Cepko, 
2001). In the vertebrate retina, for example, progenitors divide to produce seven 
major cell types, divided into the outer nuclear layer (rods and cones), the inner 
nuclear layer (horizontal, bipolar, amacrine and Müller) and the ganglion cell layer 
(Cepko, 1999; Chang and Harris, 1998; Hu and Easter, 1999; Young, 1985). Birth- 
dating and lineage studies in rat, mice, chicken and Xenopus have shown that the 
retina is generated from multi-potent progenitors that are biased to produce some cell 
types first and others later (Fekete et al., 1994; Holt et al., 1988; Moody et al., 2000; 
Pearson and Doe, 2004; Tumer and Cepko, 1987; Tumer et al., 1990; Wetts and 
Fraser, 1988). However, it is not yet known whether all cell types are bom in the 
same order in all lineages, hence further studies to follow individual lineages are 
necessary. Both intrinsic and extrinsic cues are thought to be involved in the 
regulation of temporal identity e.g. early-bom retinal cells are sensitive to extrinsic 
cues. When co-cultured with older cells, they were unable to generate early-bom
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amacrine cells and ganglion cells due to an inhibitory feedback loop from 
differentiated amacrine and ganglion cells (Belliveau and Cepko, 1999; Waid and 
McLoon, 1998). The ganglion-cell feedback loop is known to be mediated by Sonic 
hedgehog, but the identity of the signal for the amacrine cell feedback loop is 
unknown (Zhang and Yang, 2001). Most regions in the brain and spinal cord 
generate neurons first, followed by glia (Kessaris et al., 2001). This neuronal-to-glia 
switch is a good tractable system to investigate temporal patterning in the CNS. 
01ig2 and Neurogeninl are required for early-bom motor neuron identity whereas 
01ig2 and Nkx2.2 are needed for late-bom glial cell identity (Mizuguchi et al., 2001; 
Novitch et al., 2001; Zhou et al., 2001). Although a few factors influencing temporal 
neuronal identities are known in mammals, the molecular timing mechanisms 
underlying birth-order dependent neurogenesis still remain elusive.
1,2, Drosophila neurogenesis
The holometabolous insect Drosophila goes through a remarkable metamorphosis in 
which the burrowing larva completely changes its body plan to become the adult fly, 
complete with new compound eyes, antennae, wings and legs (Fig. 1.2.) (Truman et 
al., 1993). These two distinct body plans need to be powered by different nervous 
systems. Consequently, as the adult CNS develops from its larval predecessor, it is 
dramatically remodelled by several processes that are highly region specific. These 
processes include arrest and reactivation of neural progenitors and also programmed 
cell death (Bello et al., 2003; Truman and Bate, 1988; Truman et al., 1993).
1.2.1. Embryonic neurogenesis
Drosophila neurogenesis involves distinct embryonic and postembryonic phases. 
The primary precursor is the neuroblast (NB), a neuronal precursor cell similar to a 
mammalian stem cell in that it self-renews and is multi-potent, unlike the more 
restricted definition of a mammalian neuroblast. The multiple divisions of the 
neuroblast, produces with a few exceptions at the midline, all the different neuronal 
types and glia present in the brain. The formation of neuroblasts, their identification
14
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neurogenesis
FIGURE 1.2. T h e  D r o s o p h i l a  L if e  C y c l e . Periods of Neurogenesis are 
shown in green.
and description of their lineages have all been well documented (Technau GM, 2005; 
Urbach et al., 2003; Urbach and Technau, 2003a, b, 2004; Urbach R, 2004; Urbach 
et al., 2006). It has been shown that both the larval CNS and the adult CNS are 
formed from these precursor cells, which are generated early in embryogenesis with 
postembryonic neuroblasts (pNBs) sharing a lineage with their embryonic 
counterparts (Prokop et al., 1998; Prokop and Technau, 1991; Schmid et al., 1999; 
Schmidt et al., 1997; Urbach et al., 2003; Urbach and Technau, 2003a; Zhao et al.,
2007).
Neuroblasts are derived from proneural clusters in the ventral neuroectoderm, with 
the brain deriving from the anterior procephalic neuroectoderm and the ventral cord 
from the more posterior ventral neuroectoderm (Campos-Ortega, 1997; Egger et al., 
2007b; Skeath and Thor, 2003). Their formation is regulated by two opposing 
classes of genes, proneural genes such as achaete-scute that are basic helix-loop- 
helix transcription factors that promote neuroblast formation
15
Ac/Sc
FIGURE 1.4. L a t e r a l  i n h ib it io n  in  t h e  p r o n e u r a l  c l u s t e r . The
future neuroblast (red) expresses a higher level of Delta, which activates 
Notch in neighbouring cells. The Notch intracellular domain then activates 
Su[H] which in turn inhibits the proneural Achaete-Scute complex, leading to 
an epidermal fate (lilac).
(Skeath and Doe, 1996; Skeath and Thor, 2003; Urbach R, 2004) and neurogenic 
genes such as Notch and Delta that inhibit NB formation (Bhat, 1998; Hartenstein et 
al., 1994). Although all cells in each cluster are competent to become neuroblasts, 
normally only one cell does so. The remaining cells become ventral epidermal cells. 
A lateral inhibition process mediates this selection (Fig. 1.3). Originally it was 
thought that stochastic fluctuations in the levels of proneural and neurogenic genes 
randomly selected one cell to become the neuroblast in each group.
However, it is now thought that, at least in some cases, region-specific factors can 
bias one cell, the future neuroblast, to express a higher level of the Delta ligand than 
the others. This activates the Notch receptor in neighbouring cells, cleavage of Notch 
results and its interior domain binds to Suppressor of Hairless [Su(H)]. This then 
translocates to the nucleus leading to activation of specific target genes, such as 
Enhancer of split [E(spl)]. Expression of Achaete-Scute is thus inhibited (Campos-
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Ortega and Hartenstein, 1997; Campuzano and Modolell, 1992). This results in Delta 
expression being suppressed in the neighbouring cells, which become epidermal. 
Thus, the cell that initially has higher levels of proneural genes and/or Delta 
expression will acquire the neuroblast fate (Bray, 1997; Campos-Ortega and 
Hartenstein, 1997; Kunisch M, 1994; Martin-Bermudo MD, 1995).
After neuroblasts have been selected from the proneural clusters, they delaminate 
from the surface ectoderm, each occupying a fixed location and having its own 
unique identity. Each neuroblast can be identified by its gene expression profile, its 
time and place of birth and its progeny e.g. NB6-4 is located in column 6, row 4 
(Bossing et al., 1996; Egger et al., 2007b; Skeath and Thor, 2003). 30 neuroblasts 
plus one midline neuroblast are produced per hemisegment, with the CNS 
comprising 13 segments in total (Broadus et al., 1995; Schmidt et al., 1997; Skeath 
and Doe, 1996). Neuroblasts divide asymmetrically in a budding process to self- 
renew and to generate a smaller ganglion mother cell (GMC). The GMC then divides 
symmetrically to produce two post-mitotic cells (A and B), which can either be 
neurons or glia (Doe and Bowerman, 2001; Doe and Skeath, 1996). [Where the A 
and B fates are different this can be explained by the asymmetric Numb partitioning 
which represses Notch signalling in one daughter cell (Doe, 2006; Van de Bor and 
Giangrande, 2001)].
Neuroblast asymmetrical division occurs perpendicular to the apical-basal axis such 
that basal complex genes go into the GMC, which is regulated by the apical complex 
(Fig. 1.4). This requires cell polarity genes, important for cell differentiation and also 
for maintaining progenitor identity. The apical complex is composed of two sub­
complexes linked by Inscuteable. One sub-complex has aPKC phosphorylation as its 
output and is involved in targeting proteins to the basal cortex, while the output of 
the other is G-protein signalling via Gai, involved in spindle orientation and 
asymmetry. There are two basal complexes e.g. the Miranda complex functions to 
transfer Prospero into the GMC nucleus ensuring that the GMC divides only once. 
This involves aPKC phosphorylation of Lgl, part of the Lgl/Scrib/Dlg complex 
(lethal giant larva/scribble/ discs large) located at the neuroblast apical cortex, which 
subsequently dissociates from the plasma membrane. This results in uniform cortical 
distribution of the Lgl/Scrib/Dlg complex, reported to be
17
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FIGURE 1.4. N e u r o b l a s t  a s y m m e t r i c  d i v i s i o n . Neuroblasts divide 
asymmetrically to self-renew and to generate a smaller ganglion mother cell 
(GMC) which then divides symmetrically producing two neurons/glia (Purple 
circles). The apical complex of the neuroblast (blue crescent) is responsible for 
targeting proteins to the basal cortex (red crescent). The output of the Miranda 
containing basal complex is the transference of Prospero to the GMC nucleus 
(red oval) where it turns off cell-cycle genes to ensure that the GMC divides 
only once. The output of Pon/Numb is to mediate the asymmetric fates of the 
daughter cells.
responsible for the basal targeting of Prospero/Miranda/Brat at metaphase, crucial 
for GMC fate. Mutations in lgl, scrib or dig show defects in basal protein targeting, 
a smaller cortical domain and reduced spindle size, resulting in smaller neuroblasts 
and larger GMCs and hyperplasia (Albertson and Doe, 2003; Betschinger et al., 
2003; Betschinger et al., 2006; Humbert, 2003; Lee et al., 2006a; Lee et al., 2006b; 
Wodarz, 2005).
1.2.2. Temporal Transcription Factor Series
Embryonic neuroblasts express members of a transcription factor series in a specific 
sequence, which gives a temporal identity to each neuroblast, with the GMC and
18
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#1# qc
Pdm )h (^ Cas c:
jCytokinesl^ependen^^^^^^toj^^
F i g u r e  1 .5 . T h e  e m b r y o n i c  t e m p o r a l  t r a n s c r i p t i o n  f a c t o r  
SERIES. Regulatory relationship between the transcription factors in the 
neuroblasts (large circles) confers identity to the progenies of successive 
ganglion other cells and the resulting post-mitotic cells (smallest circles). For 
clarity GMCs are omitted. The transition from Hb to Kr is regulated by Seven 
up and is cytokinesis dependent whereas Kr—>^ Pdml—>^ Cas is not.
\ /
neurons sometimes expressing the same transcription factor as their progenitor 
(Brody and Odenwald, 2000; Isshiki et al., 2001; Kambadur et al., 1998). Early-bom 
neurons tend to be located deep inside the CNS whereas the late-bom neurons are 
located nearer the ventral surface of the CNS e.g. early-bom neurons express 
Hunchback (Hb) and lie deep within the brain whereas later bom neurons express 
Castor and lie in a more superficial layer (Fig. 1.5) (Isshiki et al., 2001; Kambadur et 
al., 1998). For example, NB7-3 gives rise to four individual identifiable neurons 
generated from three distinct GMCs. Hunchback (Hb) is expressed in the early sub­
lineage, while Pdml was found in the later bom neurons (Novotny et al., 2002). 
Interestingly, 4 instead of 6 post-mitotic neurons are found in this lineage and several 
studies have shown that the cause of this is apoptosis among the progeny and 
requires Notch/Numb signalling (Karcavich and Doe, 2005; Lundell et al., 2003; 
Novotny et al., 2002; Rogulja-Ortmann et al., 2007). NB7-1 generates U 1 to U5
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motor neurons and also goes through progressive restriction. High Hb specifies U 1, 
the first bom, low Hb specifies U2, Kr, Pdm and Pdm/Cas specify U3, U4 and U5 
respectively (Grosskortenhaus et al., 2006). This layering is reminiscent of the 
mammalian system where the deepest layers tend to contain early-bom neurons and 
the more superficial ones contain later-bom neurons.
Four members of the temporal transcription factor series have been identified thus 
far that are expressed in the embryo in the following sequence: Hunchback (Hb) —> 
Kmppel (Kr) —► Pdml —>■ Castor —», although in some neuroblast lineages not all of 
these are expressed (Fig. 1.5). Each gene appears to be required to activate the next 
gene in the series and to inhibit the next plus one (Brody and Odenwald, 2005; 
Grosskortenhaus et al., 2005; Isshiki et al., 2001; Kambadur et al., 1998; Pearson and 
Doe, 2003). Studies have shown that the transition from Hb to Kr expression is 
regulated by Seven up (Svp) and is cell-cycle dependent, requiring cytokinesis 
(Grosskortenhaus et al., 2005; Grosskortenhaus et al., 2006; Kinai MI, 2005). 
Although Hb is switched off in the neuroblast, its expression is maintained in the 
first bom GMC. Recent studies have reported that this maintenance is due to the 
transcription factor Prospero, which is asymmetrically segregated into the GMC 
nucleus and is cmcial in determining the GMC fate and cell-cycle exit. Prospero 
inhibits the down regulation of Hb in the GMC by antagonising Svp activity. It also 
represses cell cycle genes to prevent the GMC from dividing more than once 
(Mettler et al., 2006). In addition, it appears that, unlike cell-cycle dependent Hb to 
Kr transition, Kr —» Pdml —» Cas are still sequentially expressed in string mutants 
where the cell is blocked in G2/M. This exciting observation suggests that the NB 
may possess an intrinsic clock mechanism independent of cell-cycle progression 
(Grosskortenhaus et al., 2005). At the end of embryonic neurogenesis, most 
abdominal neuroblasts die, leaving only 3 of 30 neuroblasts per hemisegment in 
comparison to 24 neuroblasts remaining in the thoracic region. This drastic reduction 
in abdominal neuroblasts is dependent upon the axial patteming Hox protein AbdA, 
which triggers the cell death mechanism of apoptosis mediated by the proapoptotic 
gene reaper (rpr) (Peterson et al., 2002; Prokop et al., 1998; White et al., 1994). This 
late elimination of neuroblasts in the embryo makes the first major contribution to 
the segment-specific sculpting of the adult CNS.
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1.3. Postembryonic neurogenesis
The embryonic period is responsible for generating the larval CNS, whereas 
development of the larger, more complicated adult brain requires both phases 
(Fig. 1.6). The adult CNS is comprised of 10% remodelled larval cells, bom during 
embryogenesis, plus 90% imaginai cells generated in the larval and pupal stages. 
Most of the adult motoneurons derive from remodelled larval motoneurons, whereas 
all the adult intemeurons are believed to be produced during postembryonic 
neurogenesis (Skeath and Thor, 2003). The larval CNS contains approximately the 
same number (400) of neurons in each head, thoracic and abdominal segments 
(Hartenstein et al., 1987; Maurange and Gould, 2005; Skeath and Thor, 2003). In 
contrast, the adult CNS develops by dramatic postembryonic proliferation of the 
head and thoracic neuromeres, while the abdomen expands very little, with 
abdominal neuroblasts undergoing apoptosis after only a few rounds of division 
(Bello et al., 2003). This difference in expansion is reflected by post-embryonic 
neuroblasts (pNBs) producing -100 cells each in the thorax compared to -10 cells in 
the abdomen (Bello et al., 2003; Cenci and Gould, 2005; Truman and Bate, 1988).
FIGURE 1.6. T im e  c o u r s e  o f  D r o s o p h i l a  n e u r o g e n e s i s . Neuroblast 
divisions (black bars) for top to bottom: mushroom body NBs, central brain 
NBs, thoracic NBs, central abdominal NBs and terminal abdominal NBs, 
which show a gender specific proliferation window. The thoracic and 
abdominal neuromeres constitute the ventral ganglion. (Adapted from 
Maurange and Gould, 2005).
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This is because neuroblasts in the anterior regions divide for much longer periods of 
time than they do in the posterior region (Fig. 1.6).
Following embryonic neurogenesis (with the exception of the four mushroom body 
neuroblasts), neuroblasts enter a quiescent stage in which they exit the cell cycle and 
enter a GO or G1-like quiescent state. However, the factors that induce this quiescent 
state are at present unknown. Interestingly, there are segmental differences in their 
quiescence time windows such that neuroblasts in the abdomen remain in the 
quiescent state longer than their thoracic and central brain counterparts. (Fig 1.5.) 
(Maurange and Gould, 2005; Truman and Bate, 1988; Truman et al., 1993). This 
region-by-region variation suggests that the exact time of exit from quiescence is 
regulated by local rather than global cues. Exiting the quiescent state and re-entering 
the cell cycle appears to depend on two types of extrinsic factors, humoral signals 
from the circulating hemolymph and more local signals such as Anachronism (Ana) 
from a glial cell-dependent stem cell niche (Maurange and Gould, 2005). The first 
stage of neuroblast reactivation is enlargement which is dependent on amino acids in 
the diet. An unidentified fat-body mitogen is produced in response to these 
nutritional amino acids and it has been reported that in starved larvae, this mitogen is 
not produced (Britton and Edgar, 1998). Other humoral cues include Juvenile 
Hormone, reported to induce quiescent neuroblasts to re-enter the cell cycle and 
ecdysone is also thought to play a role in Drosophila (Cayre et al., 2000; Datta, 
1999; Egger et al., 2007b).
The second stage of reactivation is entry into S-phase which involves various factors 
(Truman and Bate, 1988). The gene ana encodes a secreted glycoprotein expressed 
in glial cells that are located next to the neuroblasts and although its receptor is 
unknown it appears to be required for maintenance of the quiescent state of central 
brain post-embryonic neuroblasts (pNBs), as loss-of-function mutations result in 
neuroblasts reactivating 8 hours earlier than normal (Ebens et al., 1993). Another 
factor involved in the reactivation of quiescent neuroblasts, is the protein encoded by 
the gene terribly reduced optic lobes (trol), as loss-of-function trol mutants show a 
severe delay in neuroblast reactivation. Although trol neuroblasts enlarge, they do 
not enter S phase. This can be rescued by over expression of Cyclin E, and reduced 
levels of Cyclin E are found in trol mutants, suggesting that trol neuroblasts may be 
arrested due to lack of Cyclin E (Caldwell and Datta, 1998). It has also been
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demonstrated that Trol acts downstream of Ana to either bypass or inactivate its 
repressive effect on the cell cycle (Datta, 1995). Trol also modulates hedgehog and 
branchless signalling by binding FGF in cells adjacent to the neuroblasts to initiate 
division (Lindner et al., 2007). Another factor thought to be involved is the cell 
adhesion molecule DE-Cadherin which is expressed by pNBs, their progeny and 
glial cells. Expression of a dominant-negative Cadherin in neuroblasts or glia 
resulted in a severe phenotype where neuroblast mitotic activity was greatly reduced 
(Dumstrei et al., 2003). Thus it is thought that DE-Cadherin mediates neuroblast/glia 
interactions required for neuroblast proliferation Also involved is the transcription 
factor Grainyhead (Grh), which is expressed from late embryogenesis and 
maintained in pNBs throughout larval stages (Almeida and Bray, 2005; Bray et al., 
1989; Cenci and Gould, 2005). It has been suggested that DE-Cadherin may be a 
direct target of Grh as expression is lower in grh mutant neuroblasts and the DE- 
Cadherin gene has Grh binding sites in its flanking sequences (Almeida and Bray, 
2005; Cenci and Gould, 2005; Egger et al., 2007b).
1.3.1. Postembryonic neuroblast divisions
Postembryonic neurogenesis is a major contributor to the sculpting of the adult CNS. 
Postembryonic neuroblasts divide asymmetrically, as in the embryo, and utilise 
much of the same molecular machinery as embryonic neurogenesis. It is not known 
if the temporal transcription factor series continues or how many temporal identities 
of neurons exist postembryonically. However, a transcription factor called Chinmo 
has been revealed to confer temporal identity in a dose-dependent manner on the 
neuronal progeny (y and a ’P’) of pNBs in the mushroom body (Zhu et al., 2006). 
Chinmo is not detected in the neuroblast itself, but seems to act on GMCs or early 
bom neurons.
Thoracic neuroblasts continue to proliferate for a longer period of time (128hr ALH) 
in comparison to abdominal neuroblasts (72hr ALH) and employ a different 
mechanism to end proliferation. Recently, it has been shown that central brain and 
thoracic neuroblasts stop dividing via cell-cycle exit which is dependent on Prospero 
delocalizing to their nucleus (Maurange et al., 2008). In Prospero loss-of-function 
mutants, thoracic neuroblasts proliferate into adulthood, and when Prospero is
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expressed earlier than normal, neuroblasts stop dividing prematurely. Abdominal 
neuroblasts stop dividing by undergoing apoptosis during third larval instar, 
triggered by a pulse of the Hox protein AbdA which activates one or more of the 
H99 cell death genes {rpr, hid and grim) (Bello et al., 2003). The progenitor-specific 
transcription factor Grainyhead (Grh) makes the neuroblast competent to respond 
appropriately to the AbdA signal (Almeida and Bray, 2005; Cenci and Gould, 2005; 
Egger et al., 2007a). The Polycomb (PcG) group of genes which maintain the 
inactivate states of Hox genes has recently been shown to be required for pNB 
survival (Bello et al., 2007). Proliferation defects are seen in mutants of the PcG 
genes due to loss of neuroblasts by apoptosis caused by the ectopic expression of the 
posterior Hox genes, abdA and abdB, confirming that Hox proteins have to be turned 
off in postembryonic neuroblasts to avoid them apoptosing (Bello et al., 2003). The 
result is that, at the end of postembryonic neurogenesis, each thoracic pNB has 
generated approximately 100 cells in 4 days whereas the abdominal pNBs only 
generate an average of 4 cells over a 1 day period. Interestingly, neuroblasts in the 
mushroom body (olfactory centre of the brain) do not undergo a quiescent phase and 
divide continuously, to generate about 500 cells each over 8 days (Maurange and 
Gould, 2005; Truman et al., 1993).
1.4. Apoptosis in vertebrates and insects
Programmed cell death is a fundamental process which functions during the 
development of multicellular organisms, either to eliminate surplus cells or cells that 
are damaged or infected and therefore detrimental to the organism. Cells in 
developing tissues compete to survive and proliferate and final organ size is the net 
result of integrating cell proliferation and cell death. In the developing CNS, neurons 
are dependent on a small group of highly specific proteins called neurotrophic 
factors, secreted from other neurons, glia and target tissues. Neurons are produced in 
excess and they compete with one another for survival. Neuronal death occurs in 
redundant neurons whose axons do not reach their target so are unable to receive 
neurotrophic factors and those whose axons have made erroneous connections 
(Brown et al., 2001; Oppenheim, 1991; Pettmann and Henderson, 1998).
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The core apoptotic pathway was first discovered through genetic analysis in the 
nematode C. elegans and involves specific genes which cause cell death, such as the 
initiator and effector caspases and others which protect the cells from dying, for 
example, the lAP (inhibitor of apoptosis) and Bcl-2 anti-apoptotic proteins (Ellis and 
Horvitz, 1986; Horvitz, 1999; Liu and Hengartner, 1999). Caspases comprise a 
family of cysteine aspartate proteases that can be grouped into initiator caspases and 
effector caspases. The proteolytic initiator caspases activate the more downstream 
effector caspases triggering a cascade which results in apoptosis. The Bcl-2 family of 
proteins have two sub-groups, anti-apoptotic and pro-apoptotic proteins which are 
localized to the mitochondria (Igaki, 2000). Many components are conserved 
between species but there are also important differences as well. Animals with 
complex systems immune and nervous systems possess additional proteins, 
activators, adaptors and inhibitors of cell death which precisely regulate apoptosis 
(Jacobson et al., 1997; Putcha and Johnson Jr., 2004). The core apoptotic pathway in 
C. elegans is an intrinsic pathway involving 4 genes, egl-l(egg laying abnormal), 
ced-3(cell death abnormal), ced-4, pro-apoptotic genes and ced-9 which is anti- 
apoptotic (Fig. 1.7). CED-3, the initiator caspase, is activated by CED-4 and inhibited 
by CED-9 which blocks activation by physical interaction with CED-4. Endogenous 
CED-4 is localized to the mitochondria by CED-9 (anti-apoptotic Bcl-2 family), 
however if EGL-1 (pro-apoptotic Bcl-2 family) is expressed, the CED-4/CED-9 
interaction ceases, CED-4 translocates to the nuclear membrane to activate CED-3 
resulting in programmed cell death (Chen et al., 2000; del Peso et al., 2000). Each of 
these genes has Drosophila and mammalian orthologues (Fig. 1.7) and successive 
studies have uncovered 14 mammalian caspases, 1-14 and at least 19 Bcl-2 family 
members divided into anti-apoptotic and pro-apoptotic subgroups (Riedl and Shi,
2004).
1.4.1. Mammalian apoptosis
Mammalian cells have two different pathways, the intrinsic pathway and the 
extrinsic pathway, whereas C. elegans only uses an intrinsic linear pathway. The 
extrinsic pathway in mammals is activated by extracellular cues, activating ligand- 
induced death receptors that lead to caspase activation and cell death. Cross talk
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FIGURE 1.7. V e r t e b r a t e  a n d  i n v e r t e b r a t e  a p o p t o t i c  p a t h w a y s  
(adapted from (Riedl and Shi, 2004). Schematic of the pro-apoptotic and anti- 
apoptotic proteins involved in programmed cell death in C. elegans  ^mammals and 
Drosophila. Orthologues are depicted by the same colour code. The mitochondria 
play a key role in the intrinsic mammalian pathway, but its role in Drosophila 
apoptosis is still unclear.
between both pathways can amplify the apoptotic signal (Putcha and Johnson Jr., 
2004; Shi, 2002; Twomey and McCarthy, 2005).
The intrinsic apoptotic pathway is dependent upon the depolarisation of 
mitochondria and the release of pro-apoptotic mitochondrial proteins. In mammals, 
mitochondria play a key role in apoptosis as cellular stress often causes the 
permeabilisation of the mitochondrial outer membrane and disruption of 
mitochondrial architecture, leading to the release of cytochrome c into the cytosol 
and subsequent caspase activation (McQuibban et al., 2006; Melzig et al., 1998; 
Youle and Karbowski, 2005). On mitochondrial depolarisation, the pro-apoptotic 
proteins are released into the cytosol and subsequently form a cytosolic complex 
called the apoptosome consisting of Apaf-1, cytochrome c, ATP and the initiator 
caspase-9. Apaf-1 (apoptotic protease-activating factor 1) the mammalian orthologue
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of Ced-4 is required for the recruitment and autocatalytic activation of caspase-9 
which triggers the caspase cascade leading to cell death. This requires ATP in 
mammals and nematodes and cytochrome c in mammals (Riedl and Shi, 2004; Zou 
et al., 1997) In addition to cytochrome c, other additional proteins are released from 
the mitochondria in mammals, such as Smac/Diablo which binds to lAPs (8 in 
mammals) inactivating them and thus triggering the caspase cascade and death. 
Other proteins released from mitochondria include AIF (apoptosis inducing factor), 
EndoG (endonuclease G) and Gmi/HtrA2 (mitochondrial serine protease) (Twomey 
and McCarthy, 2005).
1.4.2. Drosophila apoptosis
Drosophila has an intermediate complexity between the nematode and mammals 
(Fig. 1.7), sharing many mammalian components but with less redundancy, 
compared to mammals (Hay and Guo, 2006; Hay et al., 2004; Richardson and 
Kumar, 2002). In Drosophila, there is widespread cell death during metamorphosis 
which is regulated by steroid hormones (Baehrecke, 2000; Richardson and Kumar, 
2002; Rogulja-Ortmann et al., 2007). Several studies have identified apoptotic cells 
in the Drosophila CNS which require the proapoptotic gene reaper although how it 
is activated is still unclear (Karcavich and Doe, 2005; Lundell et al., 2003; Peterson 
et al., 2002). The Hox gene AbdA is required for apoptosis through one or more of 
the H99 (Reaper, Hid and Grim) proteins in abdominal pNBs, whereas the pioneer 
neurons dMP2 and MPI found to undergo apoptosis in a region-specific manner 
need AbdB for their survival in the posterior segments of the CNS (Bello et al., 
2003; Miguel-Aliaga and Thor, 2004; Miguel-Aliaga et al., 2008).
There are 7 Drosophila caspases, Dcp-1, Dredd/DCP-2, Drice, Drone, Decay, 
Strica/Dream and Damn/Daydream and two Bcl-2 family proteins, Buffy/dBorg2 
(anti-apoptotic) and Drob-l/Debcl/dBorg-l/dBok (pro-apoptotic) (del Peso et al., 
2000; Igaki, 2000; Igaki et al., 2002; Quinn et al., 1999; Richardson and Kumar, 
2002; Twomey and McCarthy, 2005; Zhang et al., 2000a). In addition. Drosophila 
has unique killer proteins in Reaper, Hid and Grim which have mitochondrial 
localization signals and bind to and inhibit dlAP (Brun et al., 2002; Wang et al., 
1999; White et al., 1991). Although there is no sequence homology to reaper, hid
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and grim, the mammalian protein Smac/Diablo shares functional similarities to 
them, in that it localises to the mitochondria and when released binds to the SIR 
{baculovirus lAP repeat) domain of the lAPs preventing them from inhibiting 
caspase activation in the same way as Reaper, Hid and Grim act on the dlAP 
(Denault et ah, 2007; Denault and Salvasen, 2008; Salvesen and Riedl, 2008) 
(Fig. 1.7).
Although Drosophila possess an Apaf-1 homologue. Ark, there is no conclusive 
evidence that cytochrome c is required for cell death except in spermatid 
individualisation and in the retina (Arama et al., 2003; Mendes et al., 2006; 
Rodriguez et al., 1999). However, a cell death epitope of cytochrome c is unmasked 
in Drosophila when cells are programmed to undergo apoptosis (Dorstyn et al., 
2004; Dorstyn et al., 2002; Varkey et al., 1999). Recently, the Drosophila DmHtrA2, 
homologue of the mammalian Omi/Htr2A, has been shown to reside in the 
mitochondria and on being exposed to UV-irradiation translocates to the extra 
mitochondrial compartment, cleaves dlAP and thus triggers cell death (Challa, 2007; 
Igaki, 2007). However, unlike the mammalian counterpart, which diffuses into the 
cytosol, DmHtr2A remains localised at mitochondria. Intriguingly, it appears to be 
an effector caspase-independent pathway possibly through DRONC, a fly 
counterpart of the initiator caspase, caspase-9 (Igaki et al., 2002). Although there are 
many similarities between the mammalian and Drosophila pathways, the 
involvement of mitochondria in programmed cell death in Drosophila is far from 
clear.
1.4.3. The importance of mitochondria in the CNS
Mitochondria generate cellular energy in the form of ATP which they accomplish via 
the coupling of electron transport to the generation of proton gradients for oxidative 
phosphorylation. All tissues require energy but each tissue has a different metabolic 
demand depending on its function. Tissues with high metabolic demands such as 
muscle, liver and the brain use large amounts of ATP and are therefore highly 
dependent on mitochondria which can be present in their hundreds or thousands or as 
a tubular network surrounding the nucleus of each cell (Chang and Reynolds, 2006). 
The CNS in particular uses enormous quantities of ATP, with 95% of this produced
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by oxidative phosphorylation in the mitochondria (Chang and Reynolds, 2006; 
Thome Research, 2007).
Neurons are highly-active cells that often need to grow long processes during 
development and in the adult state must support many rounds of depolarisation- 
repolarisation, vesicle release and recycling (Chada and Hollenbeck, 2004). These 
are highly dynamic processes requiring large amounts of ATP and mitochondria 
have been shown to accumulate at the growth cones of growing axons by 
chemoattraction to the Nerve Growth Factor (NOT) (Chada and Hollenbeck, 2004). 
Synapses not only have a high metabolic demand but in addition have elevated 
intracellular calcium levels also regulated by the mitochondria, therefore 
mitochondrial transport to synapses along lengthy axons is an important requirement 
for normal neuronal development and signalling (Baloh, 2008; Chada and 
Hollenbeck, 2004; Chang et al., 2006; Chang and Reynolds, 2006; Kann and 
Kovacs, 2007). Once neurons are mature, ATP is essential to maintain the ion 
gradients across the plasma membrane required for the generation, processing and 
transmission of neural impulses. Mitochondria are therefore also localised at nodes 
of Ranvier as well as synapses (Chang and Reynolds, 2006).
Evidence that the CNS places a particularly high demand on mitochondrial function 
comes from several human mitochondrial diseases that have the strongest symptoms 
in the CNS such as Leigh syndrome, Alzheimer’s, Parkinson’s, Huntington’s disease 
and Freidreich’s Ataxia (Beal, 2007; Celotto et al., 2006; Dias-Santagata et al., 2007; 
Lin and Beal, 2006; Lopez et al., 2006; Mandemakers et al., 2007). In addition, 
mutations in the mitochondrial genome are found in infantile multisystemic 
syndromes including Lebers Hereditary Optic Neuropathy (LHON) which leads to 
blindness at an early age and MELAS (mitochondrial myopathies, encephalopathy, 
lactic acidosis and stroke-like symptoms (Bebel-Garcia et al., 2004; Quinzii et al., 
2006)
1.5. Aims of the project
There have been many studies of the mechanisms involved in neuroblast formation 
and asymmetric division in the embryo. However, there have been no systematic
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screens for genes controlling either the proliferation or death of neuroblasts. 
Identification of novel genes regulating these processes will provide important 
insights into how brain size is regulated during development. Key questions remain 
as to how NBs know when to start and stop dividing and how many times they 
should divide? To address this, I conducted two genetic screens of embryonic and 
pupal-lethal mutations on Chromosome III with the aim of isolating and 
characterising mutations causing neural growth defects. As a large proportion of 
Drosophila genes have human orthologues, at least some of the genes I identify are 
likely to have conserved functions during mammalian brain development.
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Chapter 2
Materials and methods
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2.1. Drosophila Stocks
Flies were maintained on standard commeal/yeast/agar (1% autolysed yeast, 5.8% 
commeal, 5% glucose and 0.6% agar) at 25°C unless otherwise stated. For the 
MARCM screen (Fig.2.1), the 3R “clonemaker” used was the Gould lab stock A15:
CD8:GFP}LL5; P{ry^ ,neoFRT82B} P{w[+],tubPGAL80}LL3/TM6 Tb Hu 
Short genotype (elavGAL4 hsFLP;UASlacZ UASGFP;FRT82BtubGAL80/TM6 Tb 
Hu).
For selected mutants, another 3R “clonemaker” was used in MARCM experiments; 
y  w hsFLP^ tubP-GAL4 UAS-GFPnls; UAS-y^; tubP-GAL80 FRT82B/TM6B (gift 
from Gary Struhl). tub-GAL4 gives stronger GAL4 expression in progenitors than
2.2. 3R MARCM Screen
FRT 82B males were starved for 19 h and then mutagenized by feeding with 26 mM 
EMS in 1% (w/v) aqueous solution of sucrose for 18 h. (W. Chia, King’s College, 
London). FRT82B Males were then fed normally for 9 h to recover, after which they 
were mated to an excess of three times as many TM3,Sb/TM6B, Tb, Hu females for 
3 days at 25 C. Virgin and male progeny were collected to establish stocks balanced 
with TM6B. This dose gave an average of 2.5 lethal hits per chromosome arm. A 
total of 1600 lethal lines were established for the embryonic (1,250) and pupal (350) 
lethal screens (collaboration with W.Chia’s group). Pupal lethals die as 3"^  ^ instar 
larvae which enables the direct comparison of the mutant line CNS morphology with 
wild type CNS.
Mutations that are recessive lethal can only be maintained as heterozygotes. Lethal 
mutations on the 3"^  ^Chromosome are maintained using a 3"^  ^Chromosome balancer. 
Balancers are chromosomes that contain inversions and deletions and caimot 
recombine. The TM6,Tb, Hu balancer was used for both MARCM and pupal lethal 
CNS analysis as it carries the larval marker. Tubby.
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Parents for the FI MARCM screen cross (Lee and Luo, 1999) (Fig.2.L and 2.2) 
were left to lay in vials for 24hrs at 25°C. 47 hours later, L I -  L2 (0 -  48 hr ALH) 
larvae were heat shocked at 37°C for 85 minutes in a water bath. Vials were then 
kept at 18°C until wandering L3 larvae (96 hr ALH) appeared on the sides of the 
vial, 4-5 days later. Non-Tubby wandering L3 larvae were collected, partially 
dissected to expose CNS and discs and fixed in 1% Glutaraldehyde/PBS for 20 -  30 
min. The fixed larvae were washed three times in PBS for 2 min. each, and stained 
overnight at room temperature in 1 mg/ml X-gal in a X-gal stock solution (3.1mM K3 
[Fe^*(CN)6 ], 3.1mM K4[Fe^*(CN6)], ImM MgCh, 0.3% Triton-X-100, 500ml PBS). 
They were then washed in PBS, transferred to 50% glycerol/PBS for 45 min. and to 
100% glycerol for a minimum of 45 min. Following this, the CNS was dissected and 
mounted in 100% glycerol under a coverslip.
2.3. Pupal-Lethal Screen
FRT82B */TM6 Tb X FRT82B */TM6 Tb -> FRT82B */FRT82B * (non-Tb)
For the pupal lethal analysis, mutant homozygous 3"^  ^ instar wandering larvae 
(observed on side of vial) were selected for non-Tubby, having lost the Tubby 
marker. Homozygous mutant larvae from the above cross (* indicates EMS 
mutation) were raised at 25°C and dissected in PBS at wandering L3 larval stage (96 
hr ALH). Samples were fixed in 4% Formaldehyde/PBS for 30 minutes on a rotating 
platform, washed 3 times in PBS for 10 mins and incubated in 0.5% Triton X- 
100/PBS for 45 mins, the CNS was then dissected and mounted in Vectashield plus 
DAPI (Vector Labs) under a coverslip and slides were sealed with transparent nail 
varnish.
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FIGURE 2.1. MARCM CROSSING SCHEME
Using MARCM for a mosaic screen
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FIGURE 2 .2 .  M o s a i c  A n a l y s i s  w i t h  a  R e p r e s s i b l e  C e l l  M a r k e r  
(MARCM). A transgene which ubiquitously expresses a repressor of GAL 4 (tub-Gal80) is 
placed distal to the Flipase (FLP) recombinase target site (FRT). The homologue contains an 
identical FRT proximal to the mutation o f interest. Prior to mitotic recombination, GAL80 represses 
the pan-neural GAL4, preventing UAS-lacZ and UAS-GFP expression. When mitotic recombination 
is induced in G2 using heat shock to activate FLP, the homozygous mutant progeny cells lose 
GAL80 and express UAS-lacZ and UAS-GFP. The WT progeny receive two copies o f GAL80 and 
do not express the UAS reporters. Mutant clones can then be visualised by X-gal staining.
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2.4. Complementation Testing and Deficiency mapping
In order to find the number of alleles of each gene isolated, complementation tests 
were carried out between all mutant lines. Failure to complement two lethal 
mutations (ml and m2) is indicated when m l/m 2 is lethal and usually reflects two 
alleles of the same gene.
ml/TM6 Tb Hu X m2/TM6 Tb Hu —> ml/m2 (non-Tb)
For mapping experiments, deficiency stocks for chromosome III were obtained from 
the Bloomington Stock Centre. For rough mapping, I assembled a 3R deficiency 
core kit of 91 deficiencies. This consists of 26 cytologically defined deficiencies 
from Bloomington and 65 molecularly-defined deficiencies. Of these, 41 were 
generated by Exelixis (Df Exel) and 24 by Drosdel (Df ED) (Appendix Table.2.1 at 
end of Chapter). For finer mapping, additional molecularly-defined from Drosdel 
and Exelixis were used as discussed in the results chapter. Examples of balancers 
used:
Df/TM2 Ubx X m/TM6 Tb Hu Df/m ^non-Hu, non-Ubx adults = 
complements.)
D//TM3 Sb Ser X nt/TM6 Tb Hu —> Df/m(non Sb/Ser, non-Hu adults = 
complements.)
D//TM6B Tb Hu X nt/TM6B Tb Hu —> Df/m (non-Tb,non-Hu adults = 
complements.)
Mutant lines (m/TM6B Tb Hu) were crossed with the 91 deficiencies of the 3R core 
kit. Complementation tests were also carried out with all available lethal alleles in 
each candidate region. These lethal stocks were obtained from the Bloomington 
Stock Centre, Exelixis and Drosdel (Appendix Table 2.2). The MARCM screen only 
identifies phenotypes mapping to 3R whereas the pupal-lethal screen identifies 
phenotypes covering both arms of Chromosome III.
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2.5. Immunostaining
Larvae were dissected in PBS to expose the CNS and discs and fixed in 4% 
Formaldehyde/PBS for 20 minutes. Samples were then washed 3 x 1 5  minutes in 
PBT (0.5% Triton-X-100/PBS), pre-incubated in normal goat serum (NGS):PBT 
(1:9) for 30 mins, and incubated with primary antibody/NGS:PBT at 4°C on a shaker 
overnight. Samples were then washed in PBT for 3 x 15 mins, incubated in 
secondary antibody in NGSiPBT at room temperature for a few hours, followed by 2 
X 15 min washes in PBT and 1 x 30 min in PBS before being stored in Vectashield 
plus DAPI and mounted on slides. Primary antibodies used were mouse a-Mira 
(1:50), mouse a-GFP (1:1000), rabbit a-GFP (Invitrogen) (1:1000), rabbit a- 
mHSP60 (1:200) (Alonso et al., 2005), mouse a-Cytochrome C (1:200) (7H8 2C12, 
Invitrogen), rabbit a- pH3 (1:400) (Upstate Biotechnology) and mouse a-caspase 3 
(Invitrogen) (1:75). Secondary antibodies were anti-mouse and anti-rabbit 
fluorescent conjugates with Alexa 594 (red) and Alexa 488 (green) at 1:200 
(Molecular Probes). Images were collected using the Leica SP5 Confocal 
Fluorescence Microscope. All images show projections unless otherwise stated.
2.6. BrdU labelling
BrdU labels cells that have passed through S-phase. Larvae were raised on standard 
food mashed up with 1:33 of 0.2mg/ml BrdU in 40% ethanol (Sigma). BrdU-labelled 
larvae were collected, dissected and fixed in 4% formaldehyde/PBS for 30 min. 
Samples were rinsed three times in PBT, washed 2 x 15 min in DNase 1 buffer 
(66mM Tris 7.5, 5mM MgCb, ImM fresh p-mercaptoethanol), incubated at 37°C for 
30 min in 25pi DNase 1 + 0.5ml DNase 1 buffer (Promega), washed 3 x 15mins in 
PBT and blocked in 10%NGS/PBT for 30 mins mouse anti- BrdU antibody (1:50) 
was added and incubated overnight at 4°C. After washing 3 x 15mins in PBT, 
samples were incubated in anti-mouse secondary antibody (1:100) and shaken at 
room temperature 2 -3 hours followed by 2 x 15 min washes in PBT and 1 x 30 mins 
in PBS before being stored in Vectashield plus DAPI and mounted on slides.
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2.7. Adult Cuticle Preps
Flies were dehydrated in iso-propanol, dissected and legs were mounted on slides 
with 2-3 drops of both iso-propanol and Euparal (Fisher Scientific). Slides were 
baked overnight in a 65°C oven with a lOg metal weight on top of the cover slip 
(M.I.Galindo personal communication).
2.8. Sequence analysis of aless
2.8.1. Quick Fly Genomic DNA prep.
Anesthetised flies were collected and stored frozen at -80°C. Genomic DNA was 
prepared by grinding 35 flies in 200 pi fresh Buffer A with a disposable tissue 
grinder. An additional 200pl of Buffer A (5ml Buffer A solution: 500pl lOOmM 
Tris-HCl, lOOOpl lOOmM EDTA, lOOpl lOOmM NaCl, 250 pi 0.5% SDS (55°C) + 
3150pl H2O) was added, the flies were macerated until only cuticle fragments 
remained and then incubated at 65°C for 30 min. After incubation, 800pl of cold 
LiCl/KAc (1 part 5M KAc:2.5 parts 6M LiCl) solution was added and left to 
incubate on ice for at least 10 min, spun at 13,000rpm in a microcentrifuge at room 
temperature for 15 min then left on ice for a further 10 min. 1 ml of the supernatant 
was transferred to a new 2ml Eppendorf tube, avoiding the interface layer. Extraction 
with Phenol and Chloroform was then carried out by adding 500 pi phenol and 500pl 
chloroform to the sample and vortexing for 30 seconds and centrifuging at 13,000 
rpm for 2 min in a microcentrifuge. The upper aqueous layer was transferred to 
another 2ml Eppendorf tube, taking care not to remove the white interface. 1ml of 
chloroform was added, the sample then vortexed for 30 seconds, spun at 13,000 rpm 
for 2 min in a microcentrifuged and the upper layer was again transferred to a new 
2ml Eppendorf tube. 800pl of ice cold isopropanol was mixed with the sample, left 
at -20°C for 10 min then centrifuged at 13,000 rpm at room temperature for 15 min. 
The supernatant was carefully discarded, the pellet was washed in 70% ethanol, 
centrifuged at 13,000 rpm for 10 min and air dried. The DNA pellet was resuspended 
in 30pl TE buffer (1ml IM Tris.Cl (pH8), 200pl 0.5M EDTA pH8, 8 .8ml H2O) and 
stored at -20C.
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2.8.2. PCR protocol
PCR using the Robocycle (Stratagene) was carried out on the extracted DNA using 
the Expand High Fidelity Kit (Roche). Three pairs of primers (lOOpM synthesis 
from Eurogentec) covered the 8 exons of qless:
PAIR 1 -  product size 1500bp, covers exons 6, 7 and 8.
Forward primer: JGIB - TACGTGTATGGTTTATGTTAGGGTG
Reverse primer: JGIE - GTGTAGGGGAAACATTGCGAATTGC
PAIR 2 -  product size 2000bp, covers exons 2, 3, 4 and 5.
Forward primer: JG2A - AGCATAAAATGTGCGAGGCACTTGG
Reverse primer: JG2E- GGCAAAACTTGTTAGACGTGACAC
PAIR 3 -  product size 500bp, covers exon 1,
Forward primer: JG3A - GTATCTTTTCCTTTTCAAGTTTACCAG 
Reverse primer: JG3C - CCTGTTGAATTCTGTGCCTGTGTCT
1 OOng/pl DNA Ipl
Forward primer (lOpM) Ipl
Reverse primer (lOpM) Ipi
dNTPS Ipi
Buffer (2) 5 pi
Enzyme (1) O.Spl
H2O 40.5pl
50pl
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PCR Programme -  Initial denaturing 94°C for 2 min
Denaturing
Annealing
Extension
94®C for 35 sec
58°C for IminlOsec ^ 0  cycles
72°C for IminlOsec
Final extension 72°C for 9 min
2.8.3. Gel extraction
For gel extraction and purification of PCR products, 45pi PCR product + 7.5pl 
loading buffer was run on a 1% agarose gel for 10 min at 120v then approximately 
30 min at lOOv. Bands were carefully excised under UV light and transferred to an 
Eppendorf tube. The amplified DNA was then purified using the Qiagen Gel 
Extraction kit and protocol and the DNA resuspended in 30pi H2O. The purified 
DNA solution was then sequenced.
2.8.4. Sequencing
Sequencing was carried out by Cogenics. Forward primers for qless sequencing 
analysis were as follows:
Exon 1 -  GTATCTTTTCCTTTTCAAGTTTACCAG 
Exon 2 -  CTTAAGATTTGCGATTGGACATGG 
Exon 3 -  CGTTAGGTAATAACCACGAGTTC 
Exon 4 -  GGGCGTGTGTTTGGCTTTGTTTGCT 
Exon 5 -  AGCATAAAATGTGCGAAGGCACTTGG 
Exon 6 -  CACACTAATTGCCGAATTAAGCGGC 
Exon 7 -  CGATTTTTCTCTGTGCACACAACG 
Exon 8 -  TACGTGTATGGTTTATGTTAGGGTG
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2.9. Coenzvme O feeding expts
Coenzymes Q4 Q9 and Qio were all obtained from SIGMA Aldrich. All feeding 
experiments were carried out using 50pg CoQ per g fly food after an initial 
experiment using different concentration of 20pg, 50 pg, lOOpg, 200pg and 500pg 
per gram food. The food in each vial was weighed and the corresponding amount of 
CoQ powder was then added and mixed thoroughly into the food to form a 
homogenous mixture. 25 virgins of the MARCM clonemaker, y  w hsFLP^ 
tubPGAL4 UAS-GFPnls; UAS-y^; tubPGALSO FRT82B/TM6B were crossed with 
15 FRT 82B qless or Frt82B^ males and the MARCM screen protocol was followed 
as described in section 2.2 and immunostained as described in section 2.5.
To assess whether embryonic lethality could be rescued by feeding parents with 
CoQ, 50 adult heterozygotes (qless/TM6B, Tu, Hu) were left for 48 hours in vials 
containing various concentrations of Coenzyme QIC i.e. no CoQ 10, 20pg/g food, 
50pg/g food, lOOpg/g food and 200pg/g food. They were then flipped out and the 
larvae left to grow in the vials. This was carried out for 3 generations to look for 
homozygote flies, (non-Tb, non-Hu).
For control purposes and to assess the effect of CoQ on WT flies, adult WT flies 
were left for 48 hours with the same CoQ concentrations as the qless mutant 
experiments and then flipped out and the larvae left to grow. The rate of 
development was observed on the different concentrations compared to non-fed WT 
flies.
2.10. Microscopy and Image Analysis
CNS images from both screens were recorded with the light or fluorescence 
microscope (Zeiss Axiophot) using a Leica Firecam and compared to wild-type 
CNS. The pupal-lethal screen CNS images used the nuclear marker DAPI and were 
recorded using fluorescent microscopy, whereas the MARCM screen images used X- 
gal staining and were recorded using light microscopy.
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All further images were recorded by Confocal Fluorescence Microscopy (Leica 
SP5). All images were obtained with a 1.5 airy unit pinhole at a magnification of x 
1000 (objective x 100). To calculate the number of cells in a clone and the number of 
clones present for wandering L3 larvae, we took advantage of the nuclear GFP used 
to mark the clone. For each clone image, a Z-projection of a stack up to 10 sections 
spaced by 1.5 microns was calculated using maximum intensity. A transparent 
lamina was placed over each Z section image and cell outlines were drawn using a 
black felt-tip pen to avoid double counting cells in adjacent z-stacks. Cell numbers 
were analysed using Microsoft Excel. On all figures, error bars are + 1 s.d. and p- 
values were calculated using the Student’s t-test assuming equal sample variance and 
two tails.
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Table 2.1.
T a b l e  2 .1 .3R C o r e  D e f i c i e n c y  K i t
Symbol Estimated Cytology Molecularly Defined
ED 5071 81F6;82E4 3R:22995..16113
ED 5138 82D5;82F8 3R:606794.. 1090605
ED 5147 82E;83A1 3R:912842.. 1193526
ED 5156 82F8;83A4 3R: 1090655.. 1284574
EXEL 6144 83A6;83B6 3R:1328529..1438435
ED 5177 83B4;83B6 3R; 1426351..1449817
EXEL7283 83B7;83C2 3R: 1474080.. 1572399
ED 5196 83B9;83D2 3R:1510301..1833866
Df(3R)Tpl6 83Dl-2;84A4-5
Df(3R)LIN 84A4-5;84Bl-2
Df(3R)Antp-Xl 84A4-5;84C2-3
ED 7665 84B6;84E10 3R:2916249..3919805
ED 5230 84E6;85C3 3R:3803496..4478856
EXEL 6149 85A2;85A5 3R:4303420..4495213
ED 5300 85A5;85C3
EXEL 6151 85C3;85C11 3R:4878567..4983814
Df(3R)BSC24 85C4-9;85D12-14
EXEL 6286 85D2;85D15
Df(3R)GB104 85D12;85E10
EXEL 6154 85E9;85F1 3R:5619087..5754513
EXEL 6155 85F1;85F10 3R:5754513..5915190
Df(3R)BSC38 85Fl-2;86C7-8
EXEL 6159 86C3;86C7 3R:6464635..6715093
EXEL 7306 86C7;86D7 3R:6696747..6982569
ED 5514 86C7;86E14 3R;6710720..7394975
EXEL 6161 86E14;86E18 3R;7394952..7495415
EXEL 8154 86E17;86E18 3R:7472871..7585229
EXEL 7310 86F6:87A1 3R:7584321..7712831
ED 5558 86F9;87B10 3R:7654463..8269738
EXEL 7317 87B10;87C3 3R:8266959..8456337
Df(3R)Kar-Sz8 87C1-2;87D14-E1
Df(3R)ry506-85C 87Dl-2;88E5-6
EXEL 6174 88F1;88F7 3R:11154373..1133206
EXEL 7326 88F7;89A5 3R: 11363141..?
EXEL 6175 89A1;89A8
EXEL 7328 89B1;89B9 3R;11835158..11983197
EXEL 7329 89B14;89B19 3R:12067151..12184534
EXEL 6269 89B17;89D2 3R:12131453..12328470
EXEL 6270 89D2;89D8 3R: 12328472.. 12528639
Df(3R)DG2 89E7;90F1
EXEL 8165 8E8;89E11 3R:12838670..12879721
EXEL 6176 89E11;89F1 3R:12879395..12974859
ED 5780 89E11;90C1 3R:12882199..13507523
ED 5794 90B3;90E4
ED 5785 90C2;90D1 3R: 13543832.. 13769792
ED 5797 90C2;90F10 3R: 13543832.. 14068391
ED5185 90F4;91B8 3R: 13993596.. 14484708
ED 2 91A5;91F8 3R; 14224953.. 14922493
ED 5911 91C5;91F8 3R;14568649..14991505
ED 5942 91F12;92B3 3R;15052016..15660809
EXEL 6185 92E2;92F1 3R: 16135262.. 16376403
Df(3R)H-B79 92B3;92F13
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Table 2.1. continued
Symbol Estimated Cytology Molecularly defined
Df(3R)BSC43 92F7-93A1;93B3-B6
ED 10820 93A4;93B8 3R: 16774462.. 16937182
EXEL 6272 93A7;93B13 3R: 16783442.. 16938073
Df(3R)e-BS2 93C3-6;93F 14-94 A l
ED 6076 93E7;93F14 3R: 17459227.. 17868550
EXEL 6189 93F14;94A2 3R: 17859431..17950482
ED 6093 94A2;94C4 3R: 17959510.. 18552029
ED 6096 94B5;94E7 3R; 18413403.. 19047691
EXEL 6280 94E5;94E11 3R:19007696..19112013
EXEL 9012 94E9;94E13 3R: 19096137.. 19162766
Df(3R)slo3 94D4-10;96A18
EXEL 6200 96A20:96B4 3R:20585721..20711086
EXEL 6220 96A7;96C3 3R:20369520..21009495
EXEL 6201 96C2;96C4 3R;20954218..21013378
EXEL 9056 96C4;96C5 3R:21013378..21025666
EXEL 6202 96D1;96E2 3R:21109376..21330760
EXEL 6203 96E2;E6 3R;21330985..21452963
EXEL 6204 96F9;97A6 3R:21821474..22076526
Df(3R)Espl3 96F1;97B1
ED 6235 97B9;97D12 3R:22360956..22806229
EXEL 6205 97D12;97E1 3R:?..22885211
EXEL 6206 97E1;97E5 3R:22885211..22972573
Df(3R)R38.3 97E3-11;98A
Df(3R)Sq219 97F1-2;98A
Df(3R)BSC42 98Bl-2:98B3-5
EXEL 6259 98C4;98D6 3R:24141831..24416263
EXEL 6209 98D6;98E1 3R:24416263..24490049
EXEL 6210 98E1;98F5 3R:24490049..24806106
EXEL 6211 98F5;98F6 3R;24806106..24879352
Df(3R)3450 98E3;99A6-8
Df(3R)Dr-rvl 99A1-2;99B6-11
Df(3R)01215 99A6;99C1
Df(3R)127 99B5-6;99F1
Df(3R)B81 99D3;3Rt
EXEL 7378 99F8;100A5 3R:26378312..26610043
Df(3R)tll-e 100A2;100C2
Df(3R)awd-KRB 100C;100D
Df(3R)faf-BP 100D;100F5
Df(3R)04661 100D2;100F5
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Table 2.2.
T a BLE.2.2.DEFICIENCIES f o r  COMPLEMENTATION TESTING
Deficiency Cytological Location Molecularly Defined
Pupal Lethal 2v71
Df(3R)3450 98E3;99A6-8
Df(3R)Ptp99AfR31 99A7;99A7
Df(3R)L127 99B5-6;99F1
EXEL6213 99C5;99D1 3R:25692182 .25827836
4420 (l(3)99Dj) 99D6;99E3
4421 (l(3)99Di[41) 99D6;99E3
4425 ( l(3)99Ea[ll ) 99D6;99E3
10348 ( l(3)j2D5 ) 99F1;99F2
Df(3R)X3F 99D1-2;99E
EXEL 6209 98D6;98E1 3R:24416263.24490049
EXEL 6215 99F6F8 3R:?..26378570
EXEL 6216 99F6;99F7 3R:26281120.26347656
Df(3R)Dr-rvl 99A1-2;99B6-11
EXEL 6214 99D5;99E2 3R;25914470..26018056
12161 (Takr99D) 99C8;99D1 3R:25776512.25795169
15298 (CG7920) 99D1 3R:25836188.25841086
17649 ( Axn ) 99D2;99D3 3R:25848566..25861035
7340 (Med) 100C7;100D1 3R:27436770.27441478
11483 (Fer2LCH) 99F2 3R;26213554..26216306
11497 (FerlHCH) 99F2 3R:26211290.26213851
Df(3R)tll-g 99Fl-2;100B4-5
12410 (hdc) 99E4;99F1 3R:26103656..26187891
15960 (aralarl ) 99F4;99F5 3R;26271360..26281589
EXEL 9020 100A4;100A5 3R.26571483..26610037
EXEL 8194 100A4;100A7 3R:26571483..26703333
EXEL 6217 100A6;100A7 3R:26635749..26703333
EXEL 7379 100B2;100B3 3R:26917412..?
2455 ( dco ) 100B2 3R:26880904..26886931
EXEL 6219 100B4;100B8 3R;27126307..27277252
15221 (Gyc0) 100B4;100B5 3R;26960192..26997242
15328 (C G I815) lOODl 3R;27494956..27503703
15509 (pasha) lOODl 3R:27443700..27447197
18944 (CG I792) lOODl 3R:27442062..27443559
12165 (l(3)rM731) lOOCl
15857 (RpI6) 100C7 3R;27420508..27421967
15597 (CycG) 100C7
11589 (heph) 100D3;100E1 3R;27676732..27819000
10565 (krz ) 100E3 3R:27873828..27877711
11795 (mod) 100E3 3R:27877794..27880696
Pupal Lethal 2v l06
Df(3R)T-55 86F1;87A7
Exel 6173 86F1;87A7
Df(3R)M(3)76A 87E8;93C
Df(3R)sbdl05 88F9;89B10
11627 (Akt ) 89B3 3R.11924938.. 11930239
Df(3R)P115 89B7;89E7
Df(3R)sbdl04 89B5;89C
11012 (CG3590) 89E8 3R:12844496.12846810
Df(3R)Sril6 90D1;90E1
Df(3R)DG4 90D2;90F3
14930 (alt) 90C1 3R: 13505448.13505448
5949 ( osa ) 90C1;90C2 3R: 13513540.13544059
12827 (cpo ) 90D1 3R: 13769785.13769785
1034 ( Dnasell ) 90E1 3R.13845099.13846883
19261 ( h t l ) 90E2 3R: 13875093.13875130
18397 (Actn) 89E5 3R: 12801620.12803382
17153 (CG3534 ) 89E6 3R:12822174..12825172
Df(3R)Cha7 90F1;91F5
EXEL 6178 90E7;91A5 3R: 13992164.14223904
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Table 2.2
Deficiency Estimated Cytology Molecularly Defined
Pupal Lethals 2v290 and 2v316
Df(3R)Espl22 96F10-11;96F11
ED 6232 96F10;97D2 3R.21862598.22624704
Df(3R)Tl-P 97A;98Al-2
199 f E(spl) 1 96F10 3R;21866046..21866585
2124 {groucho) 96F10 3R:21867432..21875634
Pupal Lethal 2v206
ED 6235 97B9;97D12 3R:22360956.22806229
12159 (scrib) 97B9;97C1 3R:22362068..22421912
Embryonic Lethal 63
11664 ( Nmdarl/Itp-r83A ) 83A6;83A7 3R: 1334544.1349046
16420 (l tp-r83A) 83A7;83B1 3R: 1342825.1364584
18865 ( noi ) 83B4 3R:1415317.1417180
22248 (Rheb) 83B2 3R: 1394618.1396213
10214 (noi/vha) 83B4 3R: 1417453.1420429
8461 ( Snm ) 83B1;83B2 3R:1380812.1383514
16244 ( mia) 83B1 3R:1374074.1376355
Embryonic Lethals 47/87
ED 5577 86F9;87B13 3R;7654463..8303300
ED 5559 86E11;87B11 3R;7394904..8269738
EXEL 6161 86E14;86E18 3R:7394952..7495415
EXEL 6276 86E11;86E14 3R:739491L.7495408
18576 (CG6946) 86F9 3R:7648449..7650647
EXEL 6163 87AL87A4 3R: 7712923.7824992
17825 87A1 3R:7708517..7718107
8707 ( L k 6 ) 86E18 3R:7578506..7590179
10275 (neo) 86E18 3R:7595335..7604826
Embryonic Lethals 109/264 (  qless )
EXEL 6218 100B5;100B8 3R;2699486L.27126217
EXEL 7379 100B2;100B3 3R:26917412..?
11509 1(3R)00720 100B5;100B7
12165 l(3R)rM731 lOOCl
17207 CG31005 100B8 3R.27061752.27078326
Df(3R)tll-g 99Fl;100B4-5
18226 CG31004 100B5 3R.27005304..27021484
Note: Bloomington lethal stocks are given as stock number, then the allele in 
brackets.
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Chapter 3
Two Genetic Screens for neural growth
mutants
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3.1. Introduction
Although there have been many studies on neuroblast formation, asymmetric 
division and lineage mapping in the Drosophila embryo, none thus far have 
systematically screened for genes controlling neural proliferation and growth. Many 
questions therefore remain as to how neuroblasts know when to start and stop 
dividing and which factors are required to maintain their survival and mitotic 
activity. To address these issues, I have conducted two genetic screens of 
chemically-induced recessive-lethal mutations on chromosome III. The mutagen 
used, EMS (ethyl methane sulfonate), is an alkylating agent commonly used as a 
Drosophila mutagen for inducing point mutations, although at low frequency it can 
also produce rearrangements or small chromosomal deletions (Greenspan, 1997). 
The first screen, involving 350 pupal-lethal EMS lines aims to identify mutations in 
genes on both arms of chromosome III with either cell autonomous or non-cell 
autonomous requirements for CNS growth. These lines fail to develop after late 3"^  ^
instar and do not form pupae. The second screen of 1,250 embryonic-lethal EMS 
lines analyses mutations in genes on the right arm of chromosome III. MARCM is 
used to generate marked homozygous-mutant clones in a heterozygous background. 
This type of screen identifies genes with cell-autonomous requirements within the 
neuroblast lineage. I first describe the pupal-lethal and mosaic screens, and then 
characterise several mutants selected for further study.
3.2. Pupal-Lethal Screen
In the pupal-lethal screen, gene function is removed from the whole animal such that 
only those 350 lethal chromosomes surviving in the homozygous state until late L3 
and pupal stages can be analysed (for crossing scheme see Section 2.3). The screen 
involves dissecting L3 larvae, staining nuclei with DAPI and comparing the overall 
size of the CNS from homozygous mutants(non-Tb) with wild-type. From 350 
pupal-lethal lines, I identified 25 pupal-lethal mutants whose brain size and 
morphology differed considerably from the wild type. All 25 phenotypes were 
confirmed by rescreening. The phenotypes recovered fall into three classes (Fig.
3.1.and 3.2). Class A, represented by 6 lines, shows smaller than normal optic lobes
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(OL) and thorax (Th) (Fig.3.1.2 and 3.1.3). Class B, represented by 18 lines, has all 
regions of the CNS (OL, CB, Th, Ah) undersized (Figure 3.1.4 and 3.1.5). Class C, 
represented by only 1 line, shows elongation of the CNS (Figures 3.1.6). As this 
screen looks at the overall size of the CNS, neural proliferation, cell death and/or 
condensation defects could be involved.
3.2.1. Selection of mutants for mapping and characterisation
Before selecting which pupal-lethal mutations to map, I performed complementation 
tests (Table 3.1). Lines 197, 321 and 66 failed to complement each other, indicating 
three hits in one gene. In addition, lines 22 and 162 failed to complement each other, 
indicating two hits in one gene. The remaining 20 mutations represent single hits. To 
maximise the chances of mapping a new gene in the time frame available, I selected 
six pupal-lethal mutations, 2v71, 2vl06, 2v206, 2v237, 2v290, and 2v316 for further 
characterisation. Although only one allele was identified for each, their CNS 
phenotypes were dramatically different from wild type and covered all three 
phenotypic classes. Three mutants, 2v237, 2v290 and 2v316 have the Class B 
phenotype of an undersized CNS (Fig.3.1.), whereas 2v71 and 2v206 have the Class 
A phenotype of region-specific abnormalities i.e. undersized brain lobes and thorax 
and possible overgrowth of the abdomen (Fig. 3.1.). Finally, 2vl06 was chosen as it 
is the only pupal-lethal mutant with a Class C phenotype of an oversized, elongated 
CNS (Fig 3.1). The CNS phenotypes and larval morphology of each selected pupal 
lethal is described below.
2v71 (Class A)
The pupal lethal 2v71 (Fig 3.1.3) shows reduced thoracic neuromeres, optic lobes 
and central brain and also oversized abdominal neuromeres. The mutant phenotype is 
fully penetrant in that all L3 homozygotes show similar CNS and larvae are slimmer 
and more transparent than wild-type. Less than 1 % develop into pharate adults that 
do not eclose from the pupal case. Even less manage to eclose but these all have 
severe mobility impairments, lack a proboscis and die 2-3 days later. In preliminary
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Thorax
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FIGURE 3.1 P u p a l - L e t h a l  CNS P h e n o t y p e s . (1) Schematic of larval CNS. 
(2-8) All images show L3 CNS at 96 hr. Anterior is to the left and magnification is 
200x. (2) Wild type. (3 and 4) Class A phenotype shows undergrowth of brain lobes 
and thorax, and overgrowth of abdomen. (5, 6 and 7) Class B phenotype reveals 
undergrowth of the CNS. (8) Class C shows an elongated CNS phenotype, with 
oval-shaped brain lobes.
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FIGURE 3.2. PUPAL LETHAL SCREEN. CLASS A phenotype of undergrowth in the 
brain lobes and thorax and overgrowth of abdomen is represented by 6 lines. CLASS B 
phenotype of undergrowth of the CNS is represented by 18 lines. CLASS C phenotype of 
oversized CNS is represented by 1 line.
106 206 237 290 326 331 316 336 122 321 197 133 66 135 327 303 308 181 287 22 263 244 162 1080
TABLE 3.1. C o m p l e m e n t a t i o n  T e s t s  o f  t h e  p u p a l  l e t h a l s . C=complements 
F=Failure to complement, indicating hits in the same gene.
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2v106
FIGURE 3.3 MARCIM CLONES FOR 2v71 a n d  2 v 1 0 6 .  2 v 77 shows 
undersized clones in the central brain and thoracic neuromeres (brackets) and 
oversized clones in the abdominal neuromeres at 96 hr (arrow). 2vJ06 shows 
oversized clones in the abdominal neuromeres (arrowhead).
studies to test whether the 2v71 gene is required intrinsically within the NB lineage 
or whether the CNS defects are a consequence of a deficit elsewhere in the larva, I 
conducted a MARCM clonal analysis. 2v71 shows a MARCM phenotype of 
undersized clones in the thoracic neuromeres and central brain, ectopic clones in the 
abdomen and normal-sized clones in the eye discs and optic lobes (Fig. 3.3), 
indicating that the gene lies on 3R and its requirement is intrinsic within the 
neuroblast lineage, at least within the central brain, thorax and abdomen.
2vl06 (Class C)
2vl06 was the only homozygote with an over-sized CNS (Fig.3.1.8). The phenotype 
is flilly penetrant and comprises a longer ventral ganglion (Th and Ab) than wild 
type. The brain lobes, however, are oval-shaped but do not appear to be larger than 
normal. As with 2v71, the larvae themselves are slimmer and more transparent than 
wild type. Homozygous animals do not survive after L3 and as such are larval lethal. 
The fat body cells are round and present in strings rather than a flat epithelial sheet. 
To ascertain whether the 2vl06 phenotype is autonomous to the NB lineage, I 
conducted a MARCM analysis (Fig 3.3). Ectopic 2vl06 clones were observed in 
abdominal neuromeres, although the optic lobe, central brain and thoracic clones all
51
appear undersized. This indicates that the gene lies on 3R and has a neuroblast 
lineage-intrinsic phenotype of abdominal neuromere overgrowth.
2v206 (Class A)
2v206 has an undergrowth phenotype in the brain lobes and thoracic neuromeres. 
(Fig.3.1.4) The larvae are viable until late L3, very transparent, slimmer than wild 
type and the fat body is abnormal showing the same phenotype as 2vl06 i.e. fat body 
cells are present in strings rather than organised in into an epithelial sheet.
2v237.2v290 and 2v316 (Class B)
2v237, 2v290 and 2v316 (Fig. 3.1.5, 6 and 7) show similar CNS and larval 
phenotypes. The homozygous CNS is dramatically undersized throughout with 
rounded brain lobes, but the larval body is of normal size and appearance. 2v237 and 
2v316 homozygotes die at late L3 and do not form pupae, while 2v290 homozygotes 
form a puparial case but no pupa develops.
3.3. The MARCM screen
To study the late effect of mutations which cause embryonic lethality, genetic 
mosaics have to be generated. I therefore used mosaic analysis with a repressible cell 
marker (MARCM), a technique that creates labelled homozygous mutant clones in 
an unlabelled heterozygous background (see Fig. 2.1, Fig. 2.2 & Section 2.2). To 
mark clones specifically in the developing CNS and eye disc, I used the pan neural 
elav-Gal4 driver to express UAS reporter genes. elav-GAL4 is expressed in neural 
progenitors, postmitotic neurons and photoreceptors (Bello et al., 2003). Used with 
the FRT82B recombination site, this allows screening of the right arm of 
chromosome III for genes required intrinsically within the neuroblast lineages. To 
assess whether mutant phenotypes are CNS specific, clones within the eye disc were 
used as an internal control. As a control for wild-type clone size in the CNS, clones 
were made with FRT82B on an otherwise wild-type chromosome III. Figure 3.4B
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shows the wild-type pattern, observed after X-gal staining, with large blue clones 
present in the central brain, optic lobes and thoracic neuromeres. As abdominal clone 
size is small (~6 cells) and due to the perdurance of G ALSO after recombination, few 
or no clones are observed in the central abdomen. Occasionally small blue clones can 
be recovered at the tip of the abdomen where neuroblasts proliferate longer than 
other abdominal NBs. (Truman and Bate, 1988).
After screening 1,250 lines, I identified 70 with MARCM phenotypes falling into 
three categories (Fig. 3.4). Class I show a reduced clone size in the central brain and 
thoracic neuromeres such that many clones are barely detectable by X-gal staining 
(Fig. 3.4.C). Class II display clones in abdominal neuromeres indicating overgrowth 
compared to the small undetectable clones in the wild type in this region (Fig. 3.4.D 
and E). Clonal overgrowth in the central brain, optic lobes and thoracic neuromeres 
is more difficult to detect by X-gal staining and would require accurate counts of cell 
number using antibody staining. Class III have a phenotype of reduced clone size in 
thoracic neuromeres (Fig. 3.4.F). Class I is represented by 6 lines. Class II is 
represented by 52 lines and Class III is represented by 12 lines. Of the 52 Class II 
mutants, 30 show a strong clonal overgrowth phenotype whereas 22 mutants have a 
weaker and more variable overgrowth.
I selected four of the embryonic lethal mutants, 47, 72, 63 and 109 for mapping and 
further characterisation, as these had the strongest phenotypes. 109 shows a Class I 
phenotype (Fig. 3.4.C) whereas 47, 63 and 72 show Class II phenotypes (Fig. 3.4.D 
and E). Complementation tests between each of the four selected mutants and all 
other mutants in the same phenotypic class resulted in the discovery that 47 is allelic 
with a second mutation, 87. In addition, 109 is allelic to 264. These complementation 
tests define 5 complementation groups in Class I and 51 complementation groups in 
Class II with neuroblast lineage-autonomous effects on neural growth (Table 3.2).
3.4. Discussion
I successfully completed two genetic screens of 1,600 mutant EMS lines in which a 
total of 90 mutants with neural growth defects were identified. Each of the 90 mutant 
lines was re-tested to confirm all of these mutant phenotypes are reproducible. This
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FIGURE 3.4. MARCM PHENOTYPES. A) Schematic of a larval brain OL= 
Optic Lobe, Br=Central Brain, T=Thorax, A=Abdomen, ED=Eye Disc (B). B) wild- 
type pattern of clones stained with X-gal. C) Class I phenotype shows reduced clone 
size in the brain lobes and thoracic neuromeres. D and E) Class II phenotype shows 
an increase in clone size in the abdomen. F) Class III phenotype shows a reduced 
clone size in thoracic neuromeres.
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FIGURE 3.5 MARCM SCREEN. CLASS I phenotype of undersized clones in the 
central brain and thoracic neuromeres is represented by 6 lines. CLASS II, the most 
abundant phenotype of oversized clones in the abdominal neuromeres is represented by 52 
lines. CLASS III phenotype of undersized clones in the thoracic neuromeres is represented 
by 12 lines.
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TABLE 3.2. COMPLEMENTATION TEST FOR SELECTED MARCM MUTANTS
Mutant 109 47 72 63
47 c - c c
109 - c c c
72 c c - c
87 ' c FF c c
7 c c c c
107 c c c c
14 c c c c
48 c c c c
91 c c c c
63 c c c -
83 c c c c
1162 c c c c
121 c c c c
929 c c c c
123 c c c c
883 c c c c
130 c c c c
1081 c c c c
137 c c c c
783 c c c c
264 FF c c c
396 c c c c
1219 c c c c
28 c c c c
385 c c c c
288 c c c c
1202 c c c c
373 c c c c
1216 c c c c
1038 c c c c
198 c c c c
737 c c c c
91 c c c c
1105 c c c c
383 c c c c
366 c c c c
310 c c c c
368 c c c c
249 c c c c
356 c c c c
375 c c c c
348 c c c c
254 c c c c
386 c c c c
705 c c c c
695 c c c c
795 c c c c
1036 c c c c
341 c c c c
304 c c c c
345 c c c c
315 c c c c
394 c c c c
287 c c c c
282 c c c c
369 c c c c
743 c c c c
186 c c c c
C = complementation, FF = a confirmed second hit in the same gene.
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represents 5.6% of the total, roughly twice that found in the 3L screen carried out in 
the Gould lab (C. Maurange, L. Cheng, J. Pendred and A. Gould, unpublished), in 
which 90 mutants with altered clone size were recovered from 3000 EMS lines. The 
difference is probably due to a higher effectiveness of lethal EMS hits in the 3R 
mutagenesis. In fact, the average number of lethal hits per chromosome arm was 1.5 
for 3L versus 2.5 for 3R. As the vast majority of neural growth phenotypes map to 
complementation groups with only one member, it is clear that neither the 3L nor 3R 
mutagenesis were anywhere close to saturation.
The most abundant phenotype recovered from the pupal-lethal screen was 
undergrowth of the CNS with only one oversized CNS identified. This contrasts with 
the MARCM screen where the most abundant phenotype was oversized clones in the 
abdominal neuromeres. This suggests that many mutations which produce 
overgrowth in the CNS are embryonic lethal and can only be revealed by generating 
mosaic organisms. In addition, there may be fewer of these genes in the genome. 
Furthermore, the MARCM technique is biased towards this phenotype as it is simple 
to detect the presence of blue clones in the abdominal neuromeres compared to the 
few or no clones in the wild type. On the plus side, this indicates that MARCM is 
likely to be very efficient for dissecting the AbdA-dependent neuroblast apoptosis 
programme. Although X-gal staining provides a rapid assay for clone size, accurate 
cell counts within clones require higher-resolution labelling using antibodies to P-gal 
or GPP reporters. It is important to point out that the primary screens using both 
MARCM and pupal-lethal screens do not distinguish whether altered CNS or clonal 
growth is due to altered cell proliferation, cell size or cell death. To distinguish 
between these possibilities would require secondary screening, for example using 
BrdU incorporation to measure proliferation and a-activated caspase staining to 
detect dying cells.
Interestingly, the pupal-lethal screen showed that in some cases normal sized larvae 
can have small sized brains and tiny L3 larvae can have wild-type brains, suggesting 
that diploid cells and polyploid cells have different growth requirements.
To represent all growth phenotypic classes, I selected 10 mutants with interesting 
and strong phenotypes for mapping and further characterisation. Six are pupal 
lethals, five of which have a smaller than normal CNS, either region specific or the
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whole CNS, while one has an oversized CNS. The four remaining mutants are 
embryonic lethals, two of which have a second allele. Three have oversized 
abdominal clones while one has undersized clones in both the optic lobes and 
thoracic neuromeres.
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Chapter 4
Mapping and Characterisation o f  
Selected Mutants
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4.1. Introduction
This chapter discusses the mapping and characterisation of 10 selected mutants, six 
from the pupal-lethal screen and four from the MARCM screen (See chapter 3). To 
rough map each selected mutant, complementation tests were set up with a custom- 
made kit of 91 deletions assembled using the classical, Drosdel and Exelixis 
deficiencies. The classical deficiency kit available from the Bloomington Stock 
Center provides maximum coverage with a minimum number of stocks and covers a 
predicted 94.5% of the right arm of chromosome III (See appendix chapter 2, Table 
2.1). However, due to the breakpoints of these classical deficiencies being 
determined at the cytological level, there are normally grey areas on the molecular 
genome map either side of the deficiency i.e. there is uncertainty about how many 
genes are deleted. In contrast, the Exelixis and Drosdel deficiencies are molecularly 
defined to exact DNA coordinates and thus were used, where possible, to bridge the 
grey areas. Failure to complement a deficiency uncovers the candidate region in 
which the gene of interest is located (see sections 2.4.1 and 2.4.2). Once this 
candidate region has been identified, it can then be narrowed down by further 
complementation testing with every available deficiency in the region. Finally, all 
known lethal mutations previously mapped to the candidate region are also crossed 
with the mutation in question to establish whether a known gene is affected.
4.2.Failure to map 2v237, 2v316 and 72
2v237 homozygotes have a Class B phenotype of reduced brain lobes and thoracic 
neuromeres although the larval body is of normal size and morphology (see Fig. 
3.1.5). This mutation complemented all of the 91 deficiencies covering 3R. 
However, as the mutation was recovered as a pupal lethal not a 3R MARCM 
phenotype, the relevant gene may well lie on 3L. As this study was focused on genes 
on 3R, no further characterisation of 2v237 was carried out.
2v316 homozygous larvae have a Class B phenotype of an undersized CNS, with 
reductions in all regions including the optic lobes, thoracic and abdominal 
neuromeres (see Fig. 3.1.4). This is specific to the CNS as L3 larvae are of normal 
size and external morphology. The 2v316 mutation failed to complement the
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Df(3R)Exel6204 deficiency which is molecularly defined with predicted cytological 
breakpoints of 96F9-97A6. Fine mapping revealed a failure to complement 
Df(3R)Espl22 which narrowed this cytological location to 96F10;96F11. However, 
L3 larvae of the genotype 2v316/Df(3R)Espl22 show normal CNS morphology 
suggesting that the 96F10;96F11 lethal is not the primary cause of the CNS 
phenotype. As Df(3R)Espl22 is the only 3R deficiency that I found to fail to 
complement 2v316, the lethal hit associated with the undersized CNS phenotype may 
map to 3L. 2v316 was therefore not characterised further.
The embryonic lethal 72 has a Class II phenotype in FRT82B clones and is therefore 
located on 3R and autonomously required within the neuroblast lineage, at least for 
abdominal clone size (see Fig. 3.4.D). However, crossing 72 with each of the 91 
deficiencies on 3R resulted in no cases of failure to complement. One possible 
reason for this is incomplete coverage by the deficiency kit (Section 4.1). Another 
possible reason is that the clonal phenotype is synthetic, resulting from the combined 
effects of multiple viable mutations on 3R.
4.3.Pupai lethal 2v290 is an allele of E(spl)m8
The pupal lethal 2v290 has a Class B phenotype of a reduced-size CNS and normal 
larvae. When rough mapped with the 91 deficiencies for 3R, it failed to complement 
with Df(3R)Espl3 whose breakpoints are 96F1;97B1. The 2v290IDf(3R)Espl3 CNS, 
when dissected at 96hr, was found to have the same CNS phenotype as 2v290 
homozygotes, indicating that the relevant mutation lies in 96F1;97B1. Fine mapping 
resulted in failure to complement with Df(3R)Exel6204 (96F9;97A6) and 
Df(3R)Espl22 (96F10;96F11) and complementation with Df(3R)ED6232 
(96F10;97D2). This leaves a candidate interval containing 5 genes of the Enhancer 
of split complex: HLHm5, m6, HLHml, E(spl)m8 and groucho. Lethal mutations 
were available for two of these genes, E(spl)m8^^ and groucho. 2v290 failed to 
complement with E(spl)m8^^ (Fig. 4.1). E(spl)m8 encodes a HLH transcription 
factor that is a tumour suppressor and a target of Notch (Bray, 1997).
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FIGURE 4.1. C o m p l e m e n t a t i o n  m a ? o f  2v 290.
4.4. 2v206 is a mutation in scribble
2v206 has a Class A phenotype similar to that of 2v71, showing reduced brain lobes 
and thorax (Fig. 3.1.3). L3 homozygous larvae are slimmer than wild type and more 
transparent. Transparency is likely due to abnormal fat body morphology. Indeed fat 
body cells appear rounded and fail to form an epithelial sheet. Homozygous pupae 
are not found, indicating that the lethal-phase occurs during late larval development. 
2v206 failed to complement the 3R deficiency Df(3R)ED6235 whose cytological 
breakpoints are 97B9;97D12. To facilitate mapping of the EMS mutations, we 
exchanged lists of selected mutant lines with William Chia’s group, who had 
screened the same EMS mutant collection for Mira mislocalisation phenotypes 
(Slack et al., 2006). They found that the lethal mutation on the 2v206 chromosome 
maps to 97B9;97C1 which contains scribble. To confirm that 2v206 corresponds to 
scribble, I crossed it to scribble [j 7 B 3] which resulted in failure to complement. 
scribble is a well characterised and documented gene encoding a tumour suppressor 
and cell-polarity protein. Reported loss-of-function scribble mutations show
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overgrown and unstructured epithelial and neuronal tissue and giant L3 larvae 
(Bilder and Perrimon, 2000).
4.5. Pupal lethal 2v71 maps close to the 3R telomere
2v71 homozygotes have a dramatic Class A phenotype of undersized and oval 
shaped brain lobes, reduced-size thoracic neuromeres and elongated abdominal 
neuromeres (see Figs. 3.1.1 and 3.1.2). This phenotype is 100% penetrant and 100% 
of L3 homozygotes also show abnormal external morphology in that, although they 
are of normal length, they are slimmer and more transparent than wild-type. A few 
animals (less than 1%) develop into pharate adults that are unable to eclose from the 
pupal case. Rare escapers manage to eclose and show severely impaired mobility, 
lack of a proboscis and death within 2 or 3 days perhaps due to their inability to feed. 
As previously shown in Chapter 3, the MARCM phenotype is consistent with the 
pupal-lethal phenotype as ectopic clones are observed in the abdomen and clones in 
the central brain and thoracic neuromeres are greatly reduced in size (see Fig. 3.2).
To examine whether the distribution or mitoses of neuroblasts were affected in 2v71 
mutants, I used Miranda (Mira) to label neuroblasts and phospho Histone 3 (pH3) to 
mark cells in M-phase. 2v71 homozygotes have fewer-than-normal Mira-positive 
neuroblasts in both the brain lobes and thorax and correspondingly less pH3-positive 
cells in both regions at L3 (Fig. 4.2.A-F). Abdominal neuromeres, in marked 
contrast, contain ectopic Mira-positive neuroblasts and pH3 positive cells (Fig. 
4.2.A-F). This analysis indicates that neuroblasts are reduced in number in the brain 
and thorax. In the abdomen, however, some escape the normal process of apoptosis 
at 72 hrs and continue to divide for at least an additional 24 hr. This would suggest 
that 2v71 genetically interacts in some way with AbdA, Grh or H99 proapoptotic 
genes during this process (See Chapter 1).
To examine further alteration in cell proliferation in 2v71 mutants, larvae were 
continuously fed with BrdU from 0-96 hr (Fig. 4.3). In comparison to the wild-type 
CNS, 2v71 shows ectopic neural BrdU incorporation in the abdomen (Fig. 4.3.A and 
D) which is consistent with the Mira and pH3 labellings. There also appears to be 
less BrdU incorporation in the thorax and brain lobe regions than in the wild type,
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consistent with the reduced clone size observed in these regions of MARCM clones. 
Together, these results suggest that the observed size reduction in brain lobes and 
thoracic neuromeres and the expanded abdominal neuromeres of the 2v71 
homozygotes can both be accounted for by lineage-autonomous effects on neuroblast 
number and mitotic activity.
To map 2v77, complementation tests were set up with all of the 3R deficiencies. 
Only Df(3R)B81 with cytological breakpoints 99D3:3Rt failed to complement the 
2v77 lethality. 2v7I/Df(3R)B81 hemizygotes die as pharate adults unable to eclose 
from the pupal case with no escapers. When dissected from the pupal case, these 
hemizygous animals were found to lack a proboscis similar to that of the 
homozygotes. In addition, 100% of hemizygotes displayed malformed legs with 
varying degrees of severity ranging from axis duplication to truncations (Fig. 4.4.A, 
B and C). This, together with the previous observations of altered external 
morphology in 2v77 homozygotes, demonstrates that 2v77 is not a CNS-specific 
mutation but rather it likely affects many larval and imaginai tissues.
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F i g u r e  4.2 . 2v71 h o m o z y g o t e s  s h o w  r e g i o n - s p e c i f i c  a l t e r a t i o n s  
IN NEUROBLAST NUMBER. A C show wiId-type Mira/pH3 staining at 96 hr. D- 
F Mira/pH3 expression at 96 hr in 2v77 homozygotes reveals fewer than normal 
Mira-positive neuroblasts in the brain lobes and thoracic neuromeres and 
correspondingly less pH3-positive cells in both regions whereas the abdominal 
neuromeres contain ectopic Mira-positive neuroblasts that are pH3-positive and 
therefore are in M-phase (arrowheads).
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F i g u r e .4 .3 .  2 v 71 h o m o z y g o t e s  s h o w  r e g i o n - s p e c i f i c  C h a n g e s  
IN NEUROBLAST PROLIFERATION. (A and C) show wild type BrdU 
incorporation. (B and D) 2v7I shows ectopic neural BrdU incorporation 
in the abdomen (arrowhead) whereas the thorax shows less BrdU 
incorporation.
F ig u r e  4.4. 2v71/Df(3R)B81 l e g  p h e n o t y p e s . (A) wild-type leg. Dotted 
line denotes junction between tibia and tarsal segment. (B) 2v7l/Df(3R)B8I 
shows axis-duplication phenotype of the tarsal segments. (C) 2v7I/Df(3R)B8I 
shows leg-truncation phenotype of the tarsal segment.
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2v77 was fine mapped by crossing it with an additional 23 deficiencies and 25 point 
mutations available in the candidate region of 99D3;3Rt (Chapter 2, Appendix, 
Table 2.2). 2v71 complemented all the deficiencies covering the region between 
99A7 and 100F5. Unfortunately, no deficiencies covering the most distal candidate 
region from 100F5 to 3Rt were available. Together, the mapping results strongly 
suggest that the 2v71 mutation lies close to the 3R telomere. Intriguingly, Flybase 
does not report any protein-coding genes lying between 100F5 and the 3R telomere. 
This does not necessarily mean that there are none, as the heterochromatin in this 
region has not yet been well studied. In addition, genome annotation can miss small 
genes e.g. microRNAs. Although 2v71 has a very interesting and dramatic 
phenotype, the inability to map the gene responsible precluded further genetic study.
4.6. Embryonic lethal 63
The embryonic lethal 63 has a Class II MARCM phenotype of large clones in the 
abdomen similar to 47/87 (Fig.3.4D). Crossing with all 91 deficiencies on 3R 
revealed a failure to complement Df(3R)Exel6144 (83A6;83B6) and 
complementation with Df(3R)ED5177 (83B4;83B7) giving a candidate region 
spanning 83A6;83B4, consisting of 16 genes. Further crossing to 7 available lethal 
mutations in this region, indicated complementation with Nmdarl (83A6;83A7),
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FIGURE 4.5. C o m p l e m e n t a t i o n  m a p  o f  63,
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Itp-r (83A), noi (83A7;83B), Rheb (83B2), noi/vha (83B4), Snm (83B1;83B2) and 
mia (83B1). This suggests that 63 corresponds to one of the remaining 9 genes; 
CG2519, Pcmt, Pi4KIIalpha, CG14671, CG12746, CG2931, CRMP, CG2926, and 
rev7.
4.7.Embrvonic lethal alleles 47 and S7
The embryonic-lethal alleles 47 and 87 fail to complement each other and both give 
a Class II MARCM phenotype i.e. overgrowth of abdominal CNS clones (see Fig. 
3.4E). Both mutations were crossed with the 91 deficiencies on 3R. 47 had two lethal 
hits, Df(2R)Exel6174 (88F1;88F7) and Df(3R)Exel7310 (86F6;87A1), however 
allele 87 only failed with Df(3R)Exel7310. This indicates that Df(3R)Exel7310 
contains the mutation responsible for the MARCM overgrowth phenotype. Both 47 
and 87 alleles were then crossed with 9 available lethal stocks in the candidate region 
(Chapter 2, Table 2.2). Both failed with Df(3R)ED5559 (86E11;87B11) but 
complemented Df(3R)Exel5184 (86E17;86F6) and Df(3R)ED5577 (86F9;87B13), 
Df(3R)Exel6276 (86E11:86E14) and Df(3R)Exel6161 (E14;E18). This narrowed 
down the candidate region to 86F6;86F9 (Fig.4.6). This region contains 8 genes: 
CGI7360, CGI4723, CG6939, CG31116, CGI4727, CGI4724, CG6950 and 
CG6959. Although no lethal mutations are available for any
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FIGURE 4.6. C o m p l e m e n t a t i o n  m a p  o f  47 a n d  87.
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of these, CG6939 is a possible candidate as it encodes Sbf, a transcription factor with 
a yeast orthologue known to be involved in cell proliferation and growth. Yeast Sbf 
regulates the cell cycle at the G1 to S phase transition and is a target of the MAP 
kinase cascade which is required for the maintenance of cell integrity during 
asymmetric cell growth. (Madden et al., 1997).
4.8. 2vl06  corresponds to CG16941, CG8913 or CG8907
The homozygous Class C phenotype of 2vl06  differs dramatically from wild type 
and is the only one recovered from the pupal-lethal screen that possesses an 
oversized CNS (see Fig. 3.1.A and E). It has a 100% penetrant phenotype with a 
longer-than-normal ventral ganglion (thoracic and abdominal neuromeres) and 
larger-than-normal oval-shaped brain lobes. Homozygous 2vl06  larvae are 
comparable in length to wild type at L3 (96hr) but are slimmer and more transparent. 
MARCM analysis revealed that the 2vl06 has a lineage-autonomous overgrowth 
phenotype in abdominal neuromeres (see Fig. 3.3C). Initial mapping with the 3R 
deficiency kit indicated that 2vl06  fails to complement Df(3R)DG2 with cytological 
breakpoints 89E1;90F1. I then fine mapped the mutation by crossing 2vl06  to 25 
additional, available deficiencies in this region, but it complemented all of them (See 
Chapter 2, Table.2.2). In particular, 2vl06  complemented Df(3R)P115 (89B7;89E7), 
Df(3R)ED5780 (89E11;90C1), Df(3R)Exel8165 (89E8;89E11), Df(3R)Exel6176 
(89E11;89F1) and Df(3R)DG4 (90D2;90F3), narrowing the candidate region to 
89E7;89E8 (Fig. 4.7). This region contains four genes CG3534, CGI6941, CG8913 
and CG8907. However a lethal mutation is only available for CG3534^^^^^^ and 
2vl06 complements this. Of the remaining three genes, a possible candidate is 
CG8913 as Flybase annotation and BLAST searches suggest that this encodes an 
enzyme with peroxidase activity which is known to be involved in condensation of 
the CNS during embryonic development. This might account for the elongated 
abdominal neuromeres seen in 2vl06 homozygotes. Nevertheless, failure to 
condense cannot account for all aspects of the 2vl06  phenotype such as thoracic 
CNS overgrowth and ectopic neuroblasts in the abdominal CNS. The latter 
phenotype indicates that progenitor apoptosis has been blocked, suggesting that
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FIGURE 4.7. C o m p l e m e n t a t i o n  m a p  o f  2v 106,
2vl06 blocks the AbdA/Grh/H99 proapoptotic pathway at some level during this 
process (See Chapter 1). I conclude that either the CG8913 peroxidase enzyme has a 
previously uncharacterised role in proliferation or that 2vl06 maps to CGI6941 or 
CG8907.
4.9. Embryonic lethals 109 and 264 are alleles of CG31005.
The embryonic-lethal alleles 109 and 264 fail to complement each other and have a 
Class I MARCM phenotype i.e. undergrowth of the brain lobes, central brain and 
thoracic neuromeres. MARCM clones also show undergrowth in eye discs, 
indicating that the phenotype is not CNS specific (see Fig. 3.4C). 109 failed to 
complement two non-overlapping deficiencies from the 3R core kit, namely 
Df(3R)tll-e (100A2;100C1) and Df(3R)Exel6206 (97E1;97E5), indicating there are 
two lethal hits on 3R. 264, however, failed to complement Df(3R)tll-e alone, 
indicating that the mutation responsible for the CNS phenotype lies within 
100A2;100C1. Finer mapping resulted in a failure to complement with 
Df(3R)Exel6218 (100B5;100C1) and complementation with Df(3R)Exel7379
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F ig u r e  4.8. C o m p l e m e n t a t io n  m a p  o f  109/264
(100B2;100B8), Df(3R)Exel6219 (100B4;100B8) and Df(3R)tll-g (99F1;100B5) 
indicating that the 109/264 gene lies within the region 100B8;100C1, encompassing 
11 genes. Lethal mutations for 2 genes in this region were available and 
€031005^^^^"* failed to complement both 109 and 264 (Fig. 4.8). CG31005 is an 
uncharacterised gene that according to Flybase electronic annotation and BLAST 
searches, encodes a trans-hexaprenyl transferase. This gene will be the focus of 
Chapter 5.
4.3. Discussion
Of the ten selected mutations, three failed to map to 3R. The pupal lethal 2v237 
complemented all of the 3R deficiency kit indicating that it most probably lies on 3L. 
The pupal lethal 2v316 failed to complement one of the 3R deficiencies, but this did 
not uncover the relevant CNS phenotype, again suggesting that the gene in question 
lies on 3L. The embryonic lethal 72 complemented all the 3R deficiencies but as this 
has an FRT82B MARCM phenotype, the relevant gene must lie on 3R, either in 
areas not covered by the 3R deficiency kit or, alternatively, that multiple non-lethal 
genes are responsible for the phenotype. Seven out of ten mutations were
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successfully mapped to 3R using the deficiency kit. The pupal lethal 2v71 mapped to 
the heterochromatic region at the 3R telomere and 2vl06  to a region containing three 
genes respectively. Both have ectopic neuroblasts in the abdominal neuromeres 
indicating that progenitor apoptosis has been blocked, suggesting that 2v71 and 
2vl06 may be part of the AbdA/Grh/H99 pathway. Embryonic lethals 63 and 47/87 
were successfully mapped to regions consisting of 8 genes and 9 genes respectively. 
Further clues to the genes responsible could be obtained using UAS-RNAi stocks for 
each candidate available from Vienna (VDRC) or Japan (NIG).
The pupal lethals 2v206 and 2v290 were successfully mapped to scribble and 
E(spl)m8, both well known tumour-suppressor genes. Intriguingly, both 2v206 and 
2v290 have CNS phenotypes that are essentially opposite to previously identified 
loss-of-function alleles. 2v290 is an allele of E(spl)m8 which is part of the Enhancer 
o f split [E(spl-C)] complex, a target of the Notch and Delta signalling pathway (See 
Chapter 1). These are well characterised neurogenic genes required for lateral 
inhibition leading to the segregation of neural progenitor cells (neuroblasts) from the 
proneural clusters in the neuroectoderm during embryonic neurogenesis (see Chapter 
1). As there is some redundancy between the helix-loop-helix genes of the [E(spl- 
0 7 , groucho is the only one of these genes which when mutated shows an 
overproliferation phenotype of variable penetrance, resulting in some epidermal cells 
adopting the neuroblast fate (Knust et al., 1992; Schrons et al., 1992). When the 
whole complex is deleted the phenotype shows a much more severe neural 
hyperplasia. The extent of neural hyperplasia depends on the number of genes 
deleted in the complex, the more genes that are deleted the more severe is the 
phenotype (Bray, 1997; Ziemer et al., 1988). A reported homozygous deficiency for 
m7 and m8 makes it to adulthood with neural hyperplasia whereas 2v290 
homozygotes only survive to L3 with a much reduced CNS. Other studies also show 
neural hyperplasia on E(spl) loss-of-function mutations (Buescher et al., 2002; 
Corbin et al., 1991; Knust et al., 1992; Schrons et al., 1992; Ziemer et al., 1988).
2v206 is an allele of scribble with homozygous L3 larvae being slimmer, more 
transparent than normal, with a reduced-size CNS and abnormal fat body. In contrast 
to this, reported loss-of-function alleles of scribble induce neural overgrowth(Bray,
1997). scribble mutations are also reported to have unstructured imaginai discs with 
brain cells of homozygous L3 larvae losing apical-basal polarity, becoming rounded,
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lose adhesion and are able to migrate forming metastatic tumours (Bilder and 
Perrimon, 2000). L3 larvae do not pupariate and can grow for a further two weeks 
longer than normal, becoming giant bloated larvae before dying (Humbert, 2003; Wu 
et al., 2001). Scribble forms a complex at the septate junction with Discs large (Dig) 
and Lethal Giant larvae (Lgl) and the Scrib/Lgl/Dlg complex is reported to regulate 
cortical polarity, cell size and mitotic-spindle asymmetry. During 
prophase/metaphase this complex localises to the apical cortical region, then 
localises uniformly to the cortex. Mutants have defects in basal protein targeting, a 
smaller cortical domain and reduced spindle size, resulting in undersized neuroblasts 
and larger-than-normal GMCs (Albertson and Doe, 2003). In mutant larvae, 
neuroblasts and GMCs over proliferate to form neoplastic (overgrown and 
unstructured) tissue. These proteins are also thought to regulate negatively Cyclin E, 
which controls the Gl/S cell-cycle transition. In scribble mutants, the cell cycle 
slows down but cells do not exit the cell cycle and continue to proliferate resulting in 
overgrown tissue (Bilder and Perrimon, 2000; Humbert, 2003). Interestingly, there is 
one report that scribble affects the organization of the fat body with cells losing their 
structure and rounding up, due to loss of cell polarity (Wu et al., 2001). This is 
highly reminiscent of the effect of 2v206 on the fat body. Although scribble has been 
well characterised and documented, the 2v206 allele is highly atypical and therefore 
very interesting to study. One possibility is that this allele may display a tissue- 
specific phenotype in tissues such as the fat body, which may indirectly lead to a 
non-cell autonomous phenotype of under-proliferation in the CNS, due to the 
possible loss of fat-body mitogens (Britton and Edgar, 1998). This hypothesis might 
be supported if MARCM clones in the CNS had no undersized phenotype.
Finally, the embryonic-lethal alleles 109/264 were successfully mapped to a 
previously uncharacterised gene, CG31005. In the next chapter I concentrate on this 
gene as it fulfils the initial aim of the screens, which was to discover novel genes 
required for neural growth. Together, these results show that a combination of 
cytologically and molecularly-defined deficiencies provide an efficient tool kit for 
mapping mutations. However, there are limitations in that it is not always possible to 
map the mutation to a single gene, largely due to the unavailability of lethal alleles 
for all candidate genes.
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Chapter 5
Characterisation o f  the qless gene
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5.1. Introduction
The embryonic lethal alleles 109 and 264, show an undergrowth MARCM 
phenotype in the brain lobes, thoracic region and eye discs. They map to a single 
uncharacterised gene CG31005, which I have named qless. Flybase electronic 
annotation indicates that CG31005 encodes a trans-prcnyl transferase, a lipid 
enzyme catalysing the addition of isoprenoid subunits.
Prenyl transferases are referred to as polyprenyl-diphosphate synthases and are 
crucial to the biosynthesis of more than 23,000 natural isoprenoid products, which 
have different structures and consist of various numbers of five-carbon isoprenyl 
pyrophosphate (IFF) units (Liang et al., 2002; Ohnuma et al., 1998). There are three 
types of prenyl transferases: Protein prenyltransferases catalyze the addition of an 
isoprenyl pyrophosphate (isoprenoid) 5C unit to a protein or a peptide such as Ras or 
Rab to activate signal transduction; Prenyltransferases generate cyclic isoprenoids 
found in cholesterol and steroid hormones; Isoprenyl pyrophosphate synthases (cis 
or trans-pTQnyl transferases) catalyse chain elongation with substrates that are not 
protein or cholesterol derivatives. Instead allylic pyrophosphate substrates undergo 
consecutive condensation reactions with isoprenyl pyrophosphate (IFF) to produce 
linear polymers (Fig. 5.1). The cz5-type produce long isoprenoid chains of more than 
50 carbons (i.e. more than 10 isoprenoid units) such as rubber which consists of 
thousands of units. Trans-prcnyl transferases are responsible for the biosynthesis of 
shorter linear isoprenoid chains of between 6 and 10 units that are synthesized from 
famesyl pyrophosphate (C15 FFF) and IFF (Liang et al., 2002) (Fig.5.1). The all- 
trans isoprenoid side chains extend linearly within the cell membranes, although 
long side chains may form folded structures (Guo et al., 2004).
Most research on the structure of trans-prQnyl transferases has been carried out in 
bacteria, yeast and plants (Arabidopsis) although there is some characterisation of 
the rat solanesyl diphosphate synthase. (Saiki et al., 2005). These enzymes possess 
seven conserved domains including two aspartate rich DDxxD motifs which act as 
the catalytic sites, the first is the FFF binding site and the second is the IFF binding 
site. Site-directed mutagenesis in yeast has shown that all of the aspartic residues
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F I G U R E  5 .1 .  S y n t h e s i s  o f  l i n e a r  i s o p r e n o i d  c h a i n s  b y  c i s  a n d  t r a n s  
PRENYL TRANSFERASES. GPP (geranyl diphosphate), FPP (famesyl diphosphate) 
GPPS (geranylgeranyl diphosphate synthase) HexPPs (hexaprenyl diphospate 
synthase [C30]), HepPPS (C35), OPPS (C40), SPPS (C45) and DPPS (decaprenyl) 
which produces a side chain length of (C50) (adapted from (Liang et al., 2002).
except the last in the second more carboxyl terminal domain are required for 
catalytic activity. Removal of any of these abolishes catalytic activity completely. 
Other crucial residues are the small amino acids alanine and serine that regulate side- 
chain length and are located in the 4* and 5^ position upstream from the first 
DDxxD domain (Song and Poulter. C, 1994). In the avian FPPS mutants A116W and 
N114W, a side-chain length of 20 carbons instead of 30 carbons is generated. 
(Fernandez et al., 2000; Guo et al., 2004; Koyama et al., 1995; Koyama et al., 1994; 
Liang et al., 2002). The corresponding positions in the Bacillus stearothermophilis 
FPPS enzyme are naturally large residues, namely tyrosine and leucine. In this 
context, if the tyrosine residue is replaced by a smaller glycine residue, the side- 
chain length is increased from C25 to C30. These results show that catalytic activity 
and side-chain length are highly regulated by key amino acid residues upstream and
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within the active site which are critical to their structure and function (Ohnuma et al.,
1998).
5.2. Results
qless has a Class I MARCM phenotype of smaller-than-normal clones in the thorax, 
brain lobes and eye discs (See Fig. 3.4. B, C).This could be due to defective cell 
proliferation or increased cell death. To identify which trans-^xQnyX transferase 
CG31005 is most closely related to, I performed a BLAST search against the protein 
database. This revealed that CG31005 matches human PDSSI (prenyl diphosphate 
synthase sub-unit 1) with an e-value of le -106 which indicates that the probability of 
this being a random match is only 10'^ ^^ . This sub-family of trans-pTQny\ transferases 
are all involved in ubiquinone (Coenzyme Q) synthesis.
5.2.1. Biosynthesis and function of Coenzvme 0
Coenzyme Q (CoQ) also known as ubiquinone, is found naturally in all cells and
CHsO
CHsO
COOH
A ce^l CoA
HMG CoA 
1
Mevalonate 
Famesyl pj^ophosphate
-Transprenyl transferase
CH3
CH3
I
CHj-  C H  = C - CH3
FIGURE.5.2. B i o s y n t h e s i s  a n d  s t r u c t u r e  o f  C o e n z y m e  Q.
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membranes in variable amounts depending on the specific requirements of a 
particular cell or tissue. It is found in all organisms, microorganisms and plants in 
addition to animals (Crane, 2001; Lopez et al., 2006; Turunen et al., 2003). The 
endogenous biosynthesis of Coenzyme Q (CoQ) is a complicated process which 
requires two different multistep pathways. One leads to the synthesis of the ring 
structure from tyrosine or phenylalanine and consists of a redox-active 2 ,3- 
dimethoxy-5-methylbenzoquinone ring and the second leads to the formation from 
acetyl-CoA residues, via the mevalonate pathway, of a hydrophobic isoprenoid side 
chain in the 6 position due to the catalytic action of trans prenyl transferase 
(Fig.5.2). The different CoQs vary from each other in the length of their side chain 
which is indicated by a number (n) following the name. The principal coenzyme Q in 
humans and most mammals (primates, rabbit, sheep, horse, goat, pig and cow) is 
CoQ 10 which indicates that the side chain contains 10 units or 50 carbon atoms 
(Turunen et al., 2003). C0Q9 is also present but to a much lesser extent (4% in 
humans). Rats, mice and worms use mainly C0Q9 while yeast uses CoQo and E.coli 
uses CoQs.
The most studied function of CoQ is its role in the mitochondrial electron transport 
chain where it is the only component that is lipid rather than protein and is not 
anchored to the inner mitochondrial membrane (Fig 5.3). The electron transport 
chain is involved in the process of oxidative phosphorylation which generates 
cellular energy in the form of ATP. Electrons are transferred from electron donors, 
(NADH and succinate generated in the citric acid cycle) to electron acceptors via 
linked sets of four large enzymes, complexes I, II, III and IV using two electron 
carriers, the lipid-soluble Coenzyme Q and the water-soluble cytochrome c. 
Coenzyme Q carries electrons from Complex I and Complex II to Complex III and 
cytochrome c carries them from Complex III to Complex IV (Crane, 2001; 
Matthews, 1985). This generates energy in the form of a pH gradient and an electrical 
potential across the membrane which is then used to allow protons to flow back 
across the membrane through a large protein complex, ATP synthase, also located in 
the inner membrane. This produces ATP from ADP and Pi in a phosphorylation 
reaction using between 3-4 protons per ATP molecule (Boyer, 1997; Calhoun et al., 
1994; Cecchini, 2003; Hunte et al., 1990; Schultz and Chan, 2001; Trumpower, 
1990; Yoshida et al., 2001; Yoshikawa et al., 2006; Young et al., 2007).
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FIGURE 5.3. E l e c t r o n  T r a n s p o r t  C h a i n  in  t h e  I n n e r  
M i t o c h o n d r i a l  M e m b r a n e . CoQ moves within the membrane as an 
electron carrier transferring electrons from Complex I and II to Complex III. 
Complex V, ATP synthase, uses the proton gradient across the membrane to drive 
the synthesis of ATP from ADP and (Pi).
Oxidative phosphorylation can be a potential generator of reactive oxygen species 
(ROS). To combat the toxic effects of ROS, the cell has various anti-oxidants such 
as vitamin C and E and enzymes namely catalase, superoxide dismutase and 
peroxidases. Coenzyme Q itself in its reduced form, C0QH2, is also a very powerful 
anti-oxidant (Rattan, 2006; Valko et al., 2007). C0QH2 maintains the integrity of 
cellular membranes by preventing lipid peroxidation, free radicals and therefore 
preventing membrane disruption (Crane, 2001; Turunen et al., 2003).
New roles for Coenzyme Q in other cellular functions have been found in recent 
years which include regulation of transcription factor activity and cell signalling 
through redox reactions in non-mitochondrial membranes such as those of 
lysosomes, peroxisomes, golgi apparatus and plasma membranes (DeHahn et al..
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1997; Gille and Nohl, 2000; Morre, 1994; Sun et al., 1992; Turunen et al., 2003). 
CoQ carries out redox reactions in cellular membranes such as the plasma membrane 
which in eukaryotic cells contains NADH oxidase (NOX) that is not a 
transmembrane protein, rather it lies on the external side of the membrane and is 
involved in electron transport. At the cytosolic side, a quinone reductase is present 
which catalyses the reduction of CoQ to C0QH2 in the presence of NADH. C0QH2 
then shuttles electrons to NOX which is able to reduce ascorbyl radicals, produce 
superoxide and reduce protein disulfides. These NOX interchange activities are 
thought to respond to growth factors and hormones and are related to the control of 
cell growth and differentiation as well as maintaining extracellular ascorbate in the 
reduced form. CoQ also seems to be involved in lysosome redox reactions due to the 
presence of NADH-dependent CoQ reductase which translocates protons across the 
membrane.
CoQ 10 is thought to counteract mitochondrial membrane potential depolarization via 
the mitochondrial permeability transition pore (FTP). Disruption to the membrane 
due to increased permeability through the opening of the FTP e.g. due to high levels 
of Ca^ ,^ has been proposed as an early indicator of apoptosis resulting in cytochrome 
c release and caspase activation in mammals. CoQ 10 seems to be able to prevent this 
as studies show that it can counteract membrane depolarisation, cytochrome c release 
and caspase-9 activation through inhibition of the opening of the FTP and therefore 
acts as an apoptotic inhibitor (Turunen 2004, Papucci 2003).
CoQ is also involved in the regulation of gene expression and cell signalling through 
its redox activities. Electron transport is the primary generator of peroxide, H2O2 
which activates transcription factors such as NFkB which results in gene expression 
and regulation of calcium signalling. CoQs can also participate in the oxidation of 
ion channels and also of thiol groups on growth factor receptors and consequently is 
involved in the regulation of cell proliferation, however this is a new area of study 
which requires further research (Crane 2001). Another area in which CoQ plays a 
role is in the immune system. CoQ 10 increased phagocytic activity in tumour- 
induced mice and was also found to increase immunoglobins and decrease the levels 
of tumour necrosis factor-a and interleukin-6. In addition, several clinical trials 
suggest that it has a tumour suppressor effect and inhibits métastasés (Premkumar et 
al., 2007).
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It is clear that the CoQs are involved in various biological processes in all cells and 
are not just limited to their function as electron carriers. In consequence they are 
vital molecules in all organisms.
5.2.2. The CG31005 mutation responsible for the aless phenotype is identified
To identify the mutations in CG31005 responsible for the qless phenotypes, 
sequence analysis was carried out on both qless^^^ and qless^ "^* (see Material and 
Methods 2.5.2, 2.5.3 and 2.5.4). Although the qless^^"  ^ DNA lesion was not found, 
this analysis revealed qless^^^ is a G to A missense mutation in exon 4 (Fig.5.4.A) 
which changes a conserved serine to an asparagine, S214N (Fig.5.4.B). The qless 
mutation is located 10 amino acids downstream from the first DDxxD domain of the 
catalytic site and is probably positioned at the entrance of the tunnel-shaped crevice 
(Fig. 5.5.) To date, studies have shown that critical amino acids at the catalytic site 
are the aspartate residues and the 4^ and 5* amino residues upstream. This result 
identifies another crucial amino acid downstream of the first active site that is 
required for PDSSI function.
5.2.3. Dietary Coenzvme O supplementation rescues aless
The BLAST sequence analysis strongly suggests that qless is the Drosophila 
orthologue of PDSSI, the enzyme that synthesises CoQ. To ascertain whether 
embryonic lethality can be rescued by breeding flies continuously on a CoQio 
supplemented diet, ^/e^^/TMSactOFP flies were fed for three generations on 
concentrations of 20, 50 and lOOpg CoQio per gram of food. No non-GFP qless 
homozygous larvae were found indicating a failure of CoQio to rescue qless lethality.
To determine directly if the qless phenotype is due to a defect in CoQ synthesis, 
MARCM clones were generated in wild-type and qless larvae fed concentrations of 
CoQio varying from lOpg to 500pg per gram of food. All concentrations rescued the 
MARCM undergrowth phenotype to varying extents but lOpg and 20pg were less 
effective than the rest, and 200pg and 500pg produced fewer, viable L3 larvae (data
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F ig u r e  5 .4 . S e q u e n c e  a n a l y s i s  o f  qless^^^. (A ) The qless^^^ sequence 
trace bas a double peak showing a G to A mutation at position 214 within the 
CG31005 gene. B) Red box shows the conserved serine/threonine of the 
PDSSJ family in several different species. This changes to an asparagine in the 
qless^^^ mutation. Blue box is the first catalytic DDxxD domain. Green box 
shows critical residues for side-chain length
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F i g u r e  5 .5 . (A ) C r y s t a l  s t r u c t u r e  o f  t h e  A v i a n  H o m o - d i m e r  t r a n s ­
p r e n y l  TRANSFERASE. Active site is shown by red arrows. (B ) Tunnel-shaped 
crevice with DDxxD domains which act as the catalytic sites. The first DDxxD 
domain is the FPP (famesyl pyrophosphate) binding site and the second DDxxD 
domain is the IPP binding site. Black circle represents the amino acid upstream 
from the catalytic sites which is important for side-chain length. Isoprenoids are 
shown in the crevice. (Adapted from Liang et al. Eur. J. Biochem. 269, 3339- 
3354).
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FIGURE 5.6. C o e n z y m e  Q s u p p l e m e n t a t i o n  r e s c u e s  q/ess. (A) Wild 
type pattern of clones stained with nlsGFP at 96hr ALH. (B) Wild type + 
CoQio reveals an increase in clone number. (C) and (E) qless shows a 
dramatic undergrowth phenotype. (D) and (F) 50 pg/g food of CoQ 10. 
efficiently rescues qless undergrowth. An increase in number of clones is 
also observed.
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not shown). Taking these results into consideration, 50jag per gram of food was used 
as the optimal concentration in subsequent feeding experiments as this produced 
abundant larvae while efficiently rescuing the clonal undergrowth phenotype of both 
qless^^ and qless^ "^^  (Fig 5.6.). These results directly demonstrate that the qless 
undergrowth phenotype results from a CoQ deficiency and shows that qless encodes 
a trans-pxQnyX transferase.
To quantify the degree of rescue by CoQio, clone size {i.e. number of cells per clone) 
was analysed in the CoQ feeding experiments. Due to difficulties counting cells in 
large optic lobe clones, analysis was restricted to the central brain (CB) and Thorax 
(Th). The average sizes of central brain and thoracic qless clones were 8 cells (n=30) 
and 4 cells (n=30) respectively compared to wild-type values of 40 and 29 cells 
(Fig.5.7). CoQio supplementation for wild type central brain and thoracic neuromeres 
gave an average size of 41 and 31 cells respectively with a p-value of 0.18 (Fig. 5.8). 
This indicates that CoQ supplementation does not significantly increase the size of 
wild-type neuroblast clones. For qless, CoQ supplementation gave an increase of 
average clone sizes from 8 to 40 cells (central brain) and from 4 to 24 cells (thoracic 
neuromeres), with a p-value of 0.003 which is highly significant. This compares 
closely with wild-type clone sizes of 40 and 29, indicating complete rescue (Fig.5. 
8). Eye disc clones were also fully rescued (data not shown).
5.2.4 A Method to Increase MARCM clone frequency
The CoQ 10 supplementation experiments show that wild-type clone size is not 
noticeably altered. Interestingly, however, addition of C0Q4, C0Q9 or CoQ 10 does 
increase the frequency of labelled MARCM clones, both in wild-type and mutant 
cases. The average thoracic wild-type clone number increases with CoQ 
supplementation from 8 to 25 per CNS (n=6 larvae) (Fig 5.9 and 5.10). A similar 
three-fold increase in clone number is also observed with qless rescue (Fig. 5.6). 
These results show that CoQ can be used to increase the frequency of MARCM 
clones. Importantly, CoQ 10 supplementation has no ability to induce MARCM 
clones in the absence of heat shock (data not shown). One possibility is that the 
increase in frequency is due to CoQ increasing the efficiency at which Flipase
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FIGURE 5.7. C l o n e  s i z e  is  d r a m a t i c a l l y  r e d u c e d  i n  qless c l o n e s  
COMPARED TO wiLD-TYPE.( p-valuc = 0.003) Wild-type central-brain and 
thoracic MARCM clones show an average clone size of 40 and 29 cells compared 
to 8 and 4 cells in qless clones.
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FIGURE 5.8. CoQlO s u p p l e m e n t a t i o n  r e s c u e s  qless c l o n e  s i z e . 
Importantly it does not increase size of wild-type clones (p-value=0.18, not 
significant), qless clones are rescued in the central brain and thorax showing an 
increase from 8 and 4 cells respectively to 40 and 24 cells which is comparable 
wild-type clone size of 40 and 29 cells ( p-value = 0.003).
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FIGURE5.9. Q4-Q10 s u p p l e m e n t a t i o n  i n c r e a s e s  
FREQUENCY OF MARCM CLONES. (A) W ild-type pattern o f  clones  
stained with nlsGFP at 96hr ALH. (B) QIO supplement increases frequency  
o f  clones in optic lobes and thorax. (C ) Q9 and (D) Q4 supplementation  
similarly increase clone frequency.
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FIGURE 5.10. Q4-Q10 i n c r e a s e s  f r e q u e n c y  o f  MARCM 
CLONES BUT NOT CLONE SIZE. C lone size o f  thoracic neuromeres does 
not alter significantly from wild type without CoQ (29ce lls) and with Q4 
(30), Q9 (26) and QIC (31). Frequency o f  clones alters significantly (Up­
value 0.02) from 8 clones in w ild-type thoracic clones to 24 (Q4), 23 (Q 9) 
and 24 (QIO).
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induces homologous recombination between chromosomes. CoQ supplementation 
could therefore be a useful tool for increasing the frequency of MARCM or even 
other FLP-induced clones in cases where they are normally very rare e.g. in the 
embryo.
5.2.5 Different CoO side-chain lengths can rescue aless
The literature indicates that different CoQ side-chain lengths can, in some cases, 
substitute for one another (Farley et al., 1966; Hihi et al., 2003; Okada, 1998; Saiki 
et al., 2005; Scholler et al., 1970). To test whether this is the case, 50pg per gram of 
food of CoQio, C0Q9 or C0Q4 was fed to wild-type controls and qless larvae. All 
three CoQs increased clone frequency similarly for wild type and qless. In the case 
of wild type, none of the CoQs affected clone size significantly (Fig.5.9 and 5.10). In 
the case of qless, average thoracic clone size is increased from 4 to 24 cells (plus 
Qio), to 23 cells (plus Qg) and to 21 cells (plus Q4) (Fig.5.11 and 5.12). This 
indicates that side-chain lengths of 4 -10 isoprenoid units are similarly active in 
rescuing qless.
To establish the effects of loss-of-activity of qless and CoQ supplementation on 
neuroblasts, MARCM analysis was carried out using Mira as a neuroblast marker. 
Neuroblasts are found in almost all wild-type clones in the brain lobes and the 
thorax, with and without C0Q4, C0Q9 and CoQio (Figs 5.13 and 5.14 ). In the central 
brain, neuroblasts can be seen in some qless clones (Fig.5.15 A, A’, A” ) and, with 
CoQ supplementation, the frequency of clones containing a neuroblast increases 
(Fig.5.15 B-D). Similarly, in qless thoracic neuromeres at 96 hr, a neuroblast is 
present only in a small subset of clones. Typically, these rare clones are only 1-2 
cells in size whereas clones with 3 or more cells normally lack a neuroblast (Fig. 
5.16 A, A’, A” ). Supplementation with C0Q4, C0Q9 or CoQio, not only increases 
clone size but rescues the presence of the neuroblast (Fig. 5.16 B-D). These results 
indicate that dietary CoQ supplementation rescues the presence of neuroblasts as 
well as cell number in qless clones. They also provide additional evidence that 
isoprenoid side-chain lengths between 4 and 10 can functionally substitute for one 
another.
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FIGURE 5.11. D if f e r e n t  CoQ s i d e - c h a i n  l e n g t h s  
RESCUE qless CLONE SIZE. All images show L3 CNS at 96hr 
ALH. Magnification is 200x. nlsGFP labels clones. (A) qless 
undergrowth phenotype. (B -D )  show complete rescue of qless on 
supplementation with CoQ 10, Q9 and Q4 respectively.
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FIGURE 5.12. D i f f e r e n t  s i d e - c h a i n  l e n g t h s  r e s c u e  qless 
CLONE SIZE. Wild type has an average thoracic clone size o f  29 cells  
whereas qless  has an average clone size o f  4 cells. On supplementation with 
CoQ clone size increases to 21 (Q 4), 23 (Q 9) and 24 (Q I0) which shows 
rescue o f  clone size similar to w ild type (*indicates p-value = .004).
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FIGURE 5.13. N e u r o b l a s t  p a t t e r n  i n  w i l d - t y p e  b r a i n  l o b e s  w i t h  a n d  
WITHOUT CoQ SUPPLEMENTATION. All images show L3 brain lobes at 96 hr. 
Magnification is 600x. Mira (red) labels neuroblasts and nlsGFP (green) labels 
clones. Arrows indicate neuroblasts in clones (not all indicated). (A) Wild-type 
neuroblast activity without CoQ and (B-D) show similar neuroblast activity on 
supplementation with CoQ 10, CoQ9 and CoQ4 respectively. (B-D) also show an 
increase in clone frequency compared to wild-type, as indicated earlier.
89
WT(Th
A nlsGFP
B
WT + CoQIO
•Î»
B'
WT + CoQ9
WT + C0 Q4
D'
FIGURE 5.14 N e u r o b l a s t  a c t i v i t y  in  w i l d - t y p e  t h o r a c i c  n e u r o m e r e s  
WITH AND WITHOUT CoQ SUPPLEMENTATION. All images at 96 hr ALH, 
magnification lOOOx. Mira (red) labels neuroblasts and nlsGFP (green) labels 
clones. Arrows indicate the active neuroblast in clones. (A) All wild-type thoracic 
neuromeres contain a neuroblast. (B-D) Supplementation of CoQ 10, CoQ9 and 
CoQ4 similarly show the presence of a single neuroblast in every clone.
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FIGURE 5.15. D i f f e r e n t  CoQ  s i d e - c h a i n  l e n g t h s  r e s c u e  n e u r o b l a s t  
ACTIVITY IN qless BRAIN-LOBE CLONES. All images at 96hr ALH. Mira(red) 
marks the neuroblast and nlsGFP (green) labels clones. Magnification 600x. (A) 
Most qless brain-lobe clones do not contain a neuroblast and where a neuroblast is 
present the clone contains only 1-2 cells (arrow). (B-D) Supplementation with 
CoQ 10, CoQ9 or CoQ4 rescues neuroblast activity in qless clones (arrows).
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FIGURE 5.16. qless NEUROBLAST ACTIVITY IN THORACIC NEUROMERES IS 
COMPLETELY RESCUED WITH DIFFERENT C oQ  SIDE-CHAIN LENGTHS. All
images show L3 thoracic neuromeres at 96 hr ALH. Magnification is lOOOx. 
nlsGFP (green) labels clones and Mira (red) labels neuroblasts. Arrows indicate 
a neuroblast within a clone. (A) qless clones without CoQ. One clone of 2 cells 
contains a neuroblast and another clone contains no neuroblast. (B-D) 
Supplementation with CoQ 10, Q9 and Q4 respectively completely rescues 
neuroblast activity in every clone and rescues clone size.
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5.2.6. The mitochondrial stress marker Hsp60 is upregulated in aless clones
To examine the effects of loss of CoQ in mitochondria, I used Hsp60 which is a 
marker for mitochondrial stress. The Drosophila Hsp60 protein is a molecular 
chaperone located in mitochondria and is up-regulated during mitochondrial stress 
(Alonso et al., 2005; Arya et al., 2007). Co-labelling for nlsGFP and Hsp60 indicated 
that there is an up-regulation of Hsp60 in qless clones compared to heterozygous 
tissue outside the clones or to wild-type clones (Fig 5.17). Although I cannot rule out 
that this reflects an increase in mitochondrial number, this observation suggests that 
qless mitochondria are under stress.
5.2.7. The Cytochrome c cell death epitope is unmasked in aless clones
Next, to test whether increased mitochondrial stress might be associated with cell 
death, the mitochondrial protein Cytochrome c (Cyt c), was analysed. I used an 
antibody specific to an epitope of Cyt c that is unmasked when the outer 
mitochondrial membrane is disrupted. In mammals and Drosophila this unmasking 
occurs during apoptosis (Dorstyn et al., 2002; Varkey et al., 1999; Zou et al., 1997). 
Co-labelling qless clones with nlsGFP and anti-Cyt c reveals that the cell-death 
epitope is unmasked in the qless clones (Fig. 5.18 A-C). Together with the previous 
Hsp60 results, these results suggest that mitochondrial membranes lacking CoQ 
become permeabilised in a way that resembles known mitochondrial changes 
accompanying apoptosis.
5.2.8. Caspase activation in aless clones
The previous mitochondrial results suggest that cells in qless clones might be 
undergoing apoptosis. Co-labelling with mGFP and CM l, an antibody to activated 
caspase 3, was used to look at cell death. In qless clones, most cells i.e. neuroblasts 
and neurons, are CMl-positive indicating that they are undergoing programmed cell 
death (Fig. 5.19). Together with the analysis of clone size and neuroblast frequency, 
the caspase results strongly suggest that the qless undergrowth phenotype is, at least 
in part, the result of apoptosis in progenitors and post-mitotic neurons.
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F I G U R E  5.17. T h e  H s p 6 0  m i t o c h o n d r i a l  s t r e s s  m a r k e r  is  l p -  
RECULATED IN qless CLONES.  Images taken at 96hr ALH. Magnification of A 
and B is lOOOx and C is 5000x. Clones are labelled with nlsGFP (green) and 
mitochondria are labelled with Hsp60 (red). (A) Wild type clones show no 
difference in the Hsp60 levels either inside or outside the clone. (B) A qless 
clone has up-regulated Hsp60 whereas outside the clone Hsp60 levels are lower. 
(C) Higher magnification of a 2-cell clone which reveals up-regulation of Hsp60 
within the clone.
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FIGURE 5.18. C y t o c h r o m e  c  c e l l - d e a t h  e p i t o p e  is  u n m a s k e d  in  
qless CLONES. All images are brain-lobe clones at 96 hr ALH. Magnification 
is lOOOx. Cytochrome c is labelled in red and clones are labelled with nlsGFP 
(green). (A )  Wild-type clone shows that there is no difference in staining 
inside versus outside the clone. (B and C )  qless clones. Staining reveals that 
the cell-death epitope of Cytochrome c is unmasked in qless clones.
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FIGURE 5.19. qless IS r e q u i r e d  f o r  t h e  s u r v i v a l  o f  n e u r o b l a s t s  
AND NEURONS.  All images are brain-lobe clones at 96 hr ALH. Magnification 
lOOOx. Co-labelling is with CMl (red), an antibody to activated caspases and 
membrane GPP (green) to label clones. (A) In wild-type clones neither the 
neuroblast (white dotted line) nor the neurons express activated caspase. (B 
and C) In qless clones, the neuroblast and neurons are activated-caspase 
positive indicating both cell types are undergoing apoptosis.
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5.3. Discussion
I have shovm that qless encodes the fly orthologue of human PDSSI, a trans-^xQny\ 
transferase which synthesises the isoprenoid side chain of Coenzyme Q. The S214N 
mutation in qless^^^ is close to a DDxxD catalytic site, and may therefore abolish or 
diminish catalytic activity. Direct evidence for this is provided by rescue of the 
clonal undergrowth phenotype by feeding CoQ to the larvae. However embryonic 
lethality cannot be rescued by feeding adult flies CoQio as no homozygous qless 
larvae were recovered. This suggests that exogenous CoQ may not be passed 
efficiently from mother to embryo. CoQs with different side-chain lengths between 
4-10 can all rescue the MARCM undergrowth phenotype, showing they are 
functionally equivalent, at least in this context. These results correlate with various 
reports that CoQs of different isoprenoid side-chain lengths can rescue or partially 
rescue the effects of CoQ deficiencies. The worm homologue for the yeast gene coq7 
that encodes a mitochondrial protein involved in CoQ synthesis, is clk-1. When clk-1 
Caenorhabditis elegans mutants were fed dietary CoQe, CoQ?, CoQg and C0Q9, all 
could function normally with sustained growth in contrast to no CoQ at all, which 
causes growth arrest at the L2 stage. However, only CoQg and C0Q9 rescued fertility, 
indicating that the different side-chain lengths can rescue some but not all biological 
processes (Hihi et al., 2003). Studies in S. cerevisae and E. coli which normally use 
CoQô and CoQg respectively also indicated that side-chain length was not critical for 
biological function (Okada, 1998; Saiki et al., 2005). Furthermore, when genetically 
dystrophic mice deficient in C0Q9 were treated therapeutically with C0Q4 and CoQ? 
they showed a distinct improvement, with even severely dystrophic mice responding 
and able to walk (Farley et al., 1966; Scholler et al., 1970).
CoQ is an electron carrier located in the mitochondria and also protects the 
mitochondrial membrane due to its anti-oxidant properties. In addition, CoQ 10 and its 
analogues are also thought to counteract mitochondrial depolarisation via the 
mitochondrial permeability transition pore. The inner mitochondrial membrane has a 
low permeability to ions and solutes in order to save energy in the form of an 
electron and pH gradient across the membrane. To facilitate trans-membrane 
transport, it possesses a number of macromolecules that act as transporters and ion 
channels. Disruption to the membrane due to increased permeability through the 
opening of the permeability transition pore e.g. due to the release of Ca^ "^  (this could
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be tested using a UAS-GCaMP calcium sensor) (Wang et al., 2004), has been 
proposed as an early indicator of mammalian apoptosis resulting in cytochrome c 
release and caspase activation (Fontaine et al., 1998; Papucci et al., 2003; Turunen et 
al., 2003; Walter et al., 2002). Studies show that CoQio can counteract membrane 
depolarisation, cytochrome c release and caspase-9 activation and as such acts as an 
apoptotic inhibitor (Papucci et al., 2003; Turunen et al., 2003). Therefore, CoQ 
deficiency might be expected to cause disruption of the mitochondrial membrane, 
opening of the permeability pore, caspase activation and apoptosis. My Hsp60, 
cytochrome c and caspase results are consistent with this hypothesis. The 
mitochondrial Hsp60 antibody revealed mitochondrial stress. The unmasking of the 
cell-death epitope of cytochrome c points to disruption of the outer membrane, an 
indicator of apoptosis. As both neuroblasts and neurons are positive for activated 
caspase in qless clones, my results indicate that cell death operates at two levels to 
reduce clone size. First, size is reduced when post-mitotic neurons die and, second, 
there is a failure to proliferate due to neuroblast death.
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6. Discussion
To identify genes regulating CNS growth, I conducted pupal-lethal and mosaic 
genetic screens. From a total of 1,600 mutagenised chromosomes, 90 mutations 
associated with undergrowth and overgrowth phenotypes were recovered. Seven 
mutations were successfully pinpointed using deficiency mapping and three of these 
were localised to a single gene. First, I will outline the successes and limitations of 
the genetic screens and second, I will discuss in depth the characterisation of a novel 
gene from the screens that I have named qless.
6.1. Screening for neural cell proliferation and death genes.
The MARCM and pupal-lethal screens together identified 90 mutations representing 
6 distinct classes of growth phenotypes. These correspond to under-sized entire 
CNS, region-specific reduction of thorax and central brain/optic lobes, region- 
specific undergrowth of optic lobes and thorax with overgrowth of abdomen, region- 
specific undergrowth of the thorax, overgrowth of the entire CNS and region-specific 
overgrowth of the abdomen. Both screens have limitations. The mosaic screen 
misses non-cell autonomous mutations and the pupal-lethal screen is only able to 
analyse a small fraction of lethal genes as most lethals die earlier. In addition, 
although both screens have proved efficient in isolating genes affecting growth, they 
are not specific for death versus proliferation. Secondary screening of the 90 
mutations using a-activated caspase and BrdU would need to be applied to 
distinguish between these two processes. From the pupal-lethal screen of 350 
mutagenised chromosomes, 22 growth phenotypes falling into three distinct classes 
were selected. The Class A phenotype of reduced thoracic and brain lobe tissue with 
elongated abdomen was represented by 6 mutations, the Class B phenotype of a 
reduced CNS was represented by 15 mutations and finally the Class C phenotype of 
an oversized CNS was represented by 1 mutation. This suggests that overgrowth 
phenotypes are either much rarer than undergrowth phenotypes or that they are more 
frequently lethal at embryonic/early larval stages. For abdominal neuromeres at least, 
the latter possibility is consistent with the large number of overgrowth phenotypes 
recovered in the MARCM screen of embryonic-lethal mutations. Six pupal lethals, 
2v71, 2vl06, 2v206, 2v237, 2v290 and 2v316 were selected for mapping and four out
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of the six were successfully mapped. 2v237 and 2v316 failed to map to 3R and most 
probably lie on 3L. 2v71 mapped to the heterochromatic region of the 3R telomere 
and had a MARCM phenotype of under-proliferation of thoracic neuromeres and 
brain lobes and over-proliferation of the abdomen confirmed by both BrdU and 
Mira/pH3 labelling. 2vJ06 was mapped to an interval containing 3 candidate genes, 
and 2v206 and 2v290 were mapped to the well known tumour-suppressor genes, 
scribble and Enhancer o f  split m8 respectively, scribble is involved in asymmetric 
division and forms the Lgl/Scrib/Dlg complex, reported to be responsible for the 
basal targeting of Prospero/Miranda/Brat at metaphase, crucial for GMC fate 
(Albertson et al., 2004; Albertson and Doe, 2003; Betschinger et al., 2003; Doe and 
Bowerman, 2001; Humbert, 2003; Lee et al., 2006a; Wodarz, 2005). The 
E(spl)complex genes are transcriptional repressors of proneural genes, involved in 
the lateral inhibition process that determines which cells become neuroblastss and 
which become epidermal (Bray, 1997; Campos-Ortega and Hartenstein, 1997; 
Campuzano and Modolell, 1992; Kunisch M, 1994; Martin-Bermudo MD, 1995). 
Reported loss-of-function scribble mutations lead to overgrowth of neuronal tissue 
and giant L3 larvae and E(spl) loss-of-function mutations show neural hyperplasia 
with additional neuroblasts (Bilder and Perrimon, 2000; Buescher et al., 2002; 
Corbin et al., 1991; Ziemer et al., 1988). Intriguingly, both 2v206 and 2v290 are 
associated with an undersized CNS phenotype. This is in stark contrast to the over­
proliferation phenotypes described for loss-of-function mutations in these genes. 
These two alleles may therefore be interesting to follow up in the future, perhaps 
determining whether their intriguing effect on the CNS is mediated by non-cell 
autonomous effects on other growth-promoting tissues.
A larger mosaic screen of 1,250 mutagenised chromosomes identified 68 embryonic- 
lethal mutations on 3R altering the number of neurons generated per neuroblast. The 
Class I phenotype of region-specific undergrowth of the thorax and central 
brain/brain lobes was represented by 5 complementation groups, the Class II 
phenotype of region-specific overgrowth in the abdomen was represented by 51 
complementation groups, 30 of which had strong phenotypes and finally the Class III 
phenotype of region-specific undergrowth of the thorax was represented by 12 
mutations. Class II was the most abundant phenotype recovered in the mosaic screen 
and is probably due to the MARCM technique being biased towards this phenotype
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as the presence of even very small blue clones in the abdomen is easy to detect when 
compared to the wild-type pattern of none. Similarly, one caveat of the MARCM 
screen is that overgrowth of the already large thoracic and brain lobe clones is 
difficult to detect. Likewise, under-proliferation in the abdomen cannot be detected 
as the wild-type pattern is an absence of blue clones in the abdomen. Four 
complementation groups were selected for mapping from the MARCM screen: 63, 
72 and 47/87 had Class II phenotypes whereas 109/264 have a Class 1 phenotype. 
Both 62 and 47/87 were successfully mapped to 8 and 9 candidate genes 
respectively. Finally 109/264 mapped to a single uncharacterised gene CG31005, 
encoding a trans-prQnyl transferase required for Coenyme Q synthesis that I named 
qless.
Very similar frequencies of growth phenotypes were recovered from the pupal-lethal 
and mosaic screens, 6.4% for the former and 5.4% for the latter. The 3L screen 
carried out in the Gould lab (C. Maurange, L. Cheng, J. Pendred and A. Gould) 
recovered 90 mutants from 3000 EMS lines representing 3% of the total which is 
somewhat lower than the 5.6% recovered from the 3R screen. The higher percentage 
of recovered growth mutations in the 3R versus 3L screens may well reflect more 
lethal hits per chromosome arm (1.5 for 3L versus 2.5 in 3R, [A. Gould, personal 
communication]). Nevertheless, the 3R MARCM screen results also gave more hits 
than a more focused 3L MARCM screen by the William Chia lab using the same set 
of orthologue EMS lines. Although this screen scored Miranda localisation, it 
isolated alleles affecting neuroblast asymmetric division, cell fate and the orientation 
of the mitotic spindle, representing 2.8% of the total lines screened (Slack et al.,
2006). Perhaps I recovered twice the frequency because more genes affect CNS 
growth and clone size than asymmetric cell division.
6.2. qless encodes the Drosovhila orthologue of human PD SSl
Mapping and sequence analysis revealed that 109 and 264 are mutations in qless 
(CG31005)y annotated on Flybase as a trans-pxQnyX transferase. I used BLAST 
alignments to show that the closest human homologue is PDSSl, the catalytically 
active sub-unit of the PDSSl-PDSS2 holoenzyme that synthesises the isoprenoid
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side chain of CoQ. The missense mutation found in qless^^^, S214N, changes a 
conserved serine to an asparagine, ten residues dovmstream from the first DDxxD 
motif in the catalytic site, and reveals a new critical residue important for enzyme 
function. CoQio feeding experiments rescued the mutant phenotype demonstrating 
that the qless mutation causes a CoQ deficiency.
The trans-pTQnyl transferases act as complexes which can be homodimers, 
heterodimers or heterotetramers depending on the organism, and are only active after 
formation of the complex. The trans-prenyl transferases of S. Cerevisiae (CoQô) and 
B.stearothermophilis (CoQ?) form heterodimers, whereas mice (C0Q9) and S. Pombe 
(CoQ 10) form heterotetramers. This indicates that side-chain length is not specific to 
a certain type of multimeric enzyme complex (Koike-Takeshita et al., 1995; Saiki et 
al., 2005; Zhang et al., 2000b). The human enzyme is only functional as a 
heterotetramer composed of two PDSSl and two PDSS2 subunits (Lopez et al., 
2006; Mollet et al., 2007; Saiki et al., 2005). I used BLAST analysis of the 
Drosophila genome for human PDSS2 orthologues and identified CGI 0585 with an 
e-value of 2e-26, opening up the way to use Drosophila to dissect the functions of 
both PDSS subunits. As this analysis suggests that insects and humans may use the 
same heterotetrameric enzyme complex. Drosophila is likely to provide more 
insights relative to humans than yeast.
6.2.1. Functional equivalence between CoO side-chain lengths
In yeast it is known that COQl, a PDSSl orthologue, specifies the chain length of 
CoQ (Okada et al., 1996). To assess which CoQ chain length is functional in the 
Drosophila CNS, feeding experiments using C0Q4 C0Q9 and CoQ 10 were carried 
out. As each CoQ variant rescued the phenotype, it can be concluded that they are 
functionally interchangeable. However which one is normally used in the fly is 
therefore still not clear. These results are consistent with studies on a S. cerevisiae 
COQl mutant defective for hexaprenyl diphosphate synthesis. CoQs of side-chain 
lengths between 5-10 units were produced using different prenyl transferases from 
other species and were found to rescue the biological function of CoQe (Okada, 
1998). CoQe, CoQ?, CoQg and C0Q9 all rescue growth in C. elegans clk-l/coq7 null 
mutants (Hihi et al., 2003). Similarly, after treatment with C0Q4 and CoQ?
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genetically dystrophic C0Q9 deficient mice improved greatly and even the most 
severely affected mice were able to walk (Farley et aL, 1966; Scholler et al., 1970). 
As the qless mutant phenotype was rescued by C0Q4, C0Q9 and CoQ 10, this suggests 
that rather than a subtle change in side-chain length, it is more probable that the 
S214N mutation causes loss of enzyme activity, which could be due to the loss of 
serine phosphorylation or to a structural change in Qless that affects the tunnel­
shaped substrate crevice or its ability to bind substrate or to form a complex with 
PDSS2/CG10585.
6.2.2. qless links mitochondrial function to apoptosis in Drosophila
In mammals, the mitochondrial role in cell death is well documented and understood 
(See Section 1.4. and Fig 1.5), but mitochondrial involvement in cell death in 
Drosophila remains unclear. Unlike the mammalian pathway which requires 
cytochrome c to trigger apoptosis, there is no conclusive evidence that it is required 
for cell death in Drosophila except in spermatid individualization and in the retina 
(Arama et al., 2003; Mendes et al., 2006; Rodriguez et al., 1999). Nevertheless, the 
presence of Drosophila homologues of the mammalian pro-apoptotic and anti- 
apoptotic Bcl-2 family, Drob-l/Debcl/dBorg-l/dBok (pro-apoptotic) and 
Buffy/dBorg2 (anti-apoptotic) suggests conservation of elements of this 
mitochondrial pathway (Igaki, 2004; Quinn et al., 2003; Quinn et al., 1999; Zhang et 
al., 2000a). In addition, there is a Drosophila homologue for Apaf-1 (Ark), for 
Omi/HtrA2 (DmHtrA2) (Challa, 2007) and, although there is no strong sequence 
similarity between the mammalian Smac/Diablo and Drosophila Hid/Reaper/Grim, 
both bind to lAPs and are localised to mitochondria (Brun et al., 2002; Claveria et 
al., 2002; Freel et al., 2008; Oison et al., 2003a; Wang et al., 1999; Yan et al., 2006). 
Further evidence for functional equivalence to Smac/Diablo is that Hid, Grim and 
Reaper can induce death in mammalian cells through the mitochondrial pathway 
(Claveria, 2004; Olson et al., 2003b). Recent studies report that the DmHtrA2 
protein resides in the mitochondrial intermembrane space where it undergoes 
cleavage producing a mature protein that has two IBMs (lAP binding motifs). Upon 
apoptotic stimuli that induce mitochondrial permeabilization, the mature protein is
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released and binds to dlAP to inactivate it, thus promoting apoptosis via the caspase 
pathway (Challa, 2007).
My observations that neurons lacking the Qless enzyme upregulate the mitochondrial 
stress marker Hsp60 and unmask the cytochrome c epitope, an indicator of 
mitochondrial membrane disruption, provide evidence that mitochondrial disruption 
can result in caspase activation and programmed cell death in Drosophila. The 
punctate unmasked cytochrome c epitope suggests that it remains localized to the 
mitochondria This contrasts with a recent study reporting that this cytochrome c 
epitope is released from mitochondria into a diffuse cytoplasmic pattern in cells 
expressing Hid and Reaper (Abdelwahid et al., 2007) but is consistent with previous 
studies reporting exposure but not delocalisation of the cytochrome c cell-death 
epitope in apoptotic cells (Dorstyn et al., 2004; Varkey et al., 1999).
In qless neurons, it is tempting to speculate that mitochondrial disruption/ 
permeabilization causes release of mature DmHtrA2. It would be interesting to see 
whether or not the pro-apoptotic proteins Reaper, Hid, Grim and Arc (Apaf-1) 
remain localised to mitochondria in qless neurons. Further analysis of qless thus 
offers the possibility of helping to define the mitochondrial death pathway in 
Drosophila that is independent of cytochrome c release.
6.2.3 aless  ^ a fly model for human CoO deficiencies
Primary CoQio deficiency in humans has been identified in 3 prenyl transferase 
enzymes involved in CoQio synthesis. Mutations in prenyl diphosphate synthase, 
subunit 1 (PDSSl), prenyl diphosphate synthase 2 (PDSS2) and OH-benzoate 
polyprenyltransferase (COQ2) result in CoQ deficiency and oxidative 
phosphorylation disorders, with tissues and organs with high energy demands such 
as brain, muscles, eyes, and kidneys being the most affected. Neurons, in particular, 
require large amounts of ATP with 95% of this generated in the mitochondria, with 
the result that the CNS is highly susceptible to low levels of CoQio (See Chapter 1, 
Section 1.4.2.). Primary deficiencies are autosomal recessive and fall into five major 
phenotypes: Infantile encephalomyopathies, severe infantile multisystemic disease, 
cerebellar ataxias, Leigh syndrome with growth retardation, ataxia and deafness and
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isolated myopathy (Berbel-Garcia et al., 2004; DiMauro et al., 2006; DiMauro et al., 
2007; Lopez et al., 2006; Quinzii et al., 2006; Rotig et al., 2000; Rotig et al., 2007; 
Zhang et al., 2007). Clinical conditions usually appear in childhood or adolescence 
and include general tiredness, muscle weakness, mental retardation, cerebellar 
symptoms, seizures, encephalopathy, renal failure (which requires a kidney 
transplant), optic atrophy, deafness, nephritic syndrome, psychomotor and 
developmental delay, progressive ataxia, cardiomyopathy, cerebral atrophy and 
infant death.
The recessive mutation found in the PDSSl gene (the qless orthologue) caused a 
multisystem disease in two related children due to CoQio deficiency (Mollet et al.,
2007). This became more severe as the children grew older with progressive mental 
retardation, muscle weakness, deafness, obesity and optic atrophy. The recessive 
mutation in PDSS2, which encodes the small subunit of prenyl diphosphate synthase 
was extremely severe causing Leigh Syndrome and nephropathy in a male infant 
(Lopez et al., 2006). At 3 months he developed left-sided seizures which could not 
be cured with anti-epileptic drugs, his muscles became progressively weaker and he 
had feeding difficulties due to exhaustion. He died at the age of 7 months.
In addition to these diseases, low levels of CoQio are found in patients with 
neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington’s, 
mitochondrial diseases caused by mitochondrial DNA mutations, cancer, 
Friederich’s ataxia, asthma, hyperthyroidism, male infertility, AIDS and 
cardiovascular disease (Beal, 2007; Belardinelli et al., 2006; Celotto et al., 2006; 
Dias-Santagata et al., 2007; Folkers et al., 1991; Hausse et al., 2002; Lin and Beal, 
2006; Mandemakers et al., 2007; Montero et al., 2007; Ross, 2007; Rustin et al., 
2002; Young et al., 2007; Yuvaraj et al., 2007). Clinical trials using high doses of 
CoQio have shown distinct improvement in all of these illnesses. Of particular 
importance are clinical trials on breast cancer patients which have shown that CoQio 
inhibits métastasés and has a tumour suppressor effect (Premkumar et al., 2007). In 
neurodegenerative diseases, administration delays progress of the disease, and 
patients show a distinct improvement. Similarly, for Freiderich’s ataxia patients, 
either CoQio or the analogue C0Q4 have benefited them clinically (Farley et al., 
1966; Geromel et al., 2002; Hausse et al., 2002; Lerman-Sagie et al., 2001; Ross, 
2007; Rotig et al., 2000; Rustin et al., 2002). It is therefore imperative that these
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clinical diseases are diagnosed at the first signs of a possible CoQio deficiency so 
that rescue therapy can begin as soon as possible (Huntsman et ah, 2005). Although 
there is abundant clinical evidence of the therapeutic effects of CoQ, more evidence 
for mechanism-of-action is needed. As the qless mutation causes defective 
neurogenesis in the fly CNS, it provides an important fly model to study CoQ 
deficiency diseases
6.3. Conclusion.
In conclusion, both genetic screens successfully isolated a total of 90 mutations 
affecting various aspects of CNS growth. The mapping technique identified a 
previously uncharacterised Drosophila gene qless, the homologue of the human 
PDSSl gene which encodes a trans-prenyl transferase required for CoQ synthesis. 
Sequence analysis revealed the serine residue downstream from the catalytic site as a 
new critical amino acid required for its function. Characterisation of qless clones 
revealed that Coenzyme Q deficiency causes neural defects in proliferation and 
apoptosis. CoQs of different side-chain length are functionally equivalent in the 
Drosophila CNS. Interestingly, CoQ supplementation also increases the frequency of 
clones generated in mosaic animals and is therefore a useful tool for boosting FLP- 
mediated recombination events. In qless clones, mitochondrial membrane disruption 
appears to lead to caspase activation and cell death, providing a new link between 
mitochondria and programmed cell death in Drosophila which to date is still unclear. 
Taken together, these results indicate that the qless mutant lines are a valuable 
genetic tool as a potential fly model for mitochondrial disruption and apoptosis in the 
fly. Importantly, as the primary CoQio deficiencies and mitochondrial diseases are 
rare and difficult to study in humans, the qless mutant will provide an important fly 
model to study these mutations.
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